ILD, hospital admissions

ILD_HOSPITAL

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	5808
4. Check minimum number of events None	5808
5. Include endpoints None	5808
6. Filter based on genotype QC (FinnGen only)	5808

Control definitions (FinnGen only)

Control exclude: ILD_HOSPITAL_PULM_INFECT

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL
CONTROL_EXCLUDE	ILD_HOSPITAL_PULM_INFECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5808	2319	3489
Unadjusted period prevalence (%)	1.24	0.79	1.54
Median age at first event (years)	69.19	66.71	70.84

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5164: Matched controls
51639

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

5.4

323.0

3812

17811

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

1388.0

323.0

2443

UGC12

NOMESCO Finland

Flexible bronchoscopy

11.3

323.0

1816

2366

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4973.5

323.0

2729

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

323.0

3427

17982

TGC00

NOMESCO Finland

Bronchial lavation

33.9

323.0

1171

443

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

323.0

467

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

323.0

2577

9873

XG410

NOMESCO Finland

Flow-volume spirometry

9.4

323.0

782

961

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

25.6

323.0

1784

1042

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

323.0

389

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

19.8

323.0

990

610

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

8.7

323.0

1881

3201

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

9672.2

323.0

1436

L04AX05

ATC

pirfenidone; oral

+∞

321.2

305

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.7

303.7

1178

3029

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.7

299.9

837

1455

R06.0

ICD-10 Finland

Dyspnoea

3.3

299.6

2110

9039

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

10.5

272.7

561

595

GD1AD

NOMESCO Finland

Thorax CT examination

7.0

246.1

652

1039

R03AC02

ATC

salbutamol; inhalant

2.7

245.8

3080

18319

L04AX01

ATC

azathioprine; systemic

8.0

245.0

593

826

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

215.1

2310

12223

J96.1

ICD-10 Finland

Chronic respiratory failure

10.2

213.3

443

472

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

95.8

207.1

229

L01XE31

ATC

[U] nintedanib; oral

+∞

205.6

196

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.2

204.1

699

1521

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

29.4

198.0

271

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

194.9

812

2156

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.1

191.5

657

1427

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

56.3

181.3

216

L04AA06

ATC

mycophenolic acid; systemic

13.2

174.2

316

254

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.5

168.6

899

2927

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

167.6

160

J01MA14

ATC

moxifloxacin; systemic

3.7

165.7

825

2539

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

150.7

144

A02BC02

ATC

pantoprazole; systemic

2.2

148.9

3623

26577

P01BA02

ATC

hydroxychloroquine; oral

3.9

148.2

679

1935

R03BB04

ATC

tiotropium bromide; inhalant

3.0

143.4

954

3609

L01EX09

ATC

nintedanib; oral

+∞

136.0

130

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.3

133.3

536

1349

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.3

129.4

526

1336

M05BA04

ATC

alendronic acid; oral

3.2

121.4

713

2451

R05

ICD-10 Finland

Cough

2.4

118.5

1237

6009

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

118.2

113

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

6.2

117.8

334

567

Z94.2

ICD-10 Finland

Lung transplant status

243.5

116.3

119

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

112.7

1176

5693

C03CA01

ATC

furosemide; systemic

2.0

111.9

2161

13702

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.7

111.0

404

915

GDG10

NOMESCO Finland

Bilateral transplantation of lung

371.7

109.8

110

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

105.9

1146

5627

J01MA12

ATC

levofloxacin; systemic

2.1

92.0

1264

6858

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

90.2

868

3976

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

10.0

89.5

185

192

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

88.3

1059

5396

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

434.8

86.3

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.0

85.1

1411

8216

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.8

84.2

592

2261

J01AA02

ATC

doxycycline; systemic

1.9

84.0

3943

32580

J47

ICD-10 Finland

Bronchiectasis

6.1

82.9

236

401

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

81.8

1187

6541

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

81.2

679

2872

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

80.1

2371

16779

R4110

NOMESCO Finland

Physiotherapy

1.9

79.8

1506

9165

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

79.3

538

2007

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.4

78.0

299

709

R02

ICPC

Shortness of breath/dyspnoea

2.3

77.9

786

3665

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

77.8

469

1614

J43.9

ICD-10 Finland

Emphysema, unspecified

6.3

75.4

209

343

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.8

75.2

156

163

R03BA08

ATC

ciclesonide; inhalant

2.9

74.5

496

1825

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

73.9

1248

7252

WX892

NOMESCO Finland

Monitored bed care

2.7

73.5

555

2206

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.9

73.4

161

186

R04.2

ICD-10 Finland

Haemoptysis

3.7

69.8

325

919

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

69.5

855

4353

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.9

68.5

447

1619

R50.9

ICD-10 Finland

Fever, unspecified

2.1

67.9

853

4379

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

3.8

67.5

306

845

J01FA06

ATC

roxithromycin; oral

1.7

67.1

2024

14150

L04AA13

ATC

leflunomide; oral

5.0

66.1

223

463

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

66.0

1653

10907

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

65.5

1061

6029

XG466

NOMESCO Finland

Sleep oxymetry

3.9

64.3

284

767

L04AD01

ATC

ciclosporin; systemic

6.1

61.4

173

290

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

61.2

1162

6971

R03AK08

ATC

formoterol and beclometasone; inhalant

3.8

60.9

272

741

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

60.2

1082

6362

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

60.1

452

1782

H02AB07

ATC

prednisone; oral

2.0

59.7

854

4602

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

19.5

58.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

58.2

409

1548

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

5.3

58.1

186

364

WW200

NOMESCO Finland

Immunization

4.4

58.0

219

511

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.5

57.7

480

2004

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.6

56.0

170

313

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

55.6

903

5098

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

55.1

939

5391

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

12.9

55.1

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.5

55.0

202

459

R05

ICPC

Cough

1.8

54.8

1084

6557

J01CA04

ATC

amoxicillin; systemic

1.6

54.5

3737

31758

XX4BW

NOMESCO Finland

32.7

53.9

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

53.7

324

1110

127

Kela drug reimbursment

Transplant complication

6.3

53.6

147

238

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.8

53.5

126

164

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

5.2

52.1

168

332

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

51.1

1398

9316

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.6

49.4

232

659

ZX120

NOMESCO Finland

Intravenous

2.2

49.2

567

2774

R28

ICPC

Limited function/disability (R)

5.9

48.9

142

248

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

47.7

1548

10773

N02AX02

ATC

tramadol; systemic, rectal

1.5

47.3

2168

16434

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.8

47.1

111

145

ZX108

NOMESCO Finland

Inhalation

9.2

46.8

100

111

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

17.6

46.2

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.5

45.9

225

662

R81

ICPC

Pneumonia

3.2

45.5

253

819

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

44.9

737

4146

J84

ICD-10 Finland

Other interstitial pulmonary diseases

+∞

44.8

GX1K5

NOMESCO Finland

Diffusion capacity

24.5

44.5

R99

ICPC

Respiratory disease other

4.7

44.0

154

333

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

42.7

685

3816

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

41.9

397

1764

R03BA02

ATC

budesonide; inhalant

1.8

41.9

830

4971

C07AB07

ATC

bisoprolol; oral

1.5

40.4

2646

21423

R03BA01

ATC

beclometasone; inhalant

1.8

40.3

719

4154

A02BC01

ATC

omeprazole; systemic

1.6

40.1

1476

10503

WX721

NOMESCO Finland

Oxygen concentrator therapy

21.3

40.0

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.9

39.8

171

451

I50.0

ICD-10 Finland

Congestive heart failure

2.0

38.7

541

2855

A02BC05

ATC

esomeprazole; systemic

1.5

38.5

1922

14631

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.0

38.5

160

410

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

38.2

2095

16267

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.6

37.7

175

493

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.8

37.4

109

192

GDA10

NOMESCO Finland

Biopsy of lung

20.2

37.4

A07AA02

ATC

nystatin; oral

2.3

37.3

385

1784

J01FA10

ATC

azithromycin; systemic

1.5

37.0

2281

18100

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

36.9

954

6167

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

36.6

341

1501

R03DC03

ATC

montelukast; oral

1.8

36.1

664

3868

R03BA05

ATC

fluticasone; inhalant

1.7

35.8

828

5178

WZC30

NOMESCO Finland

Teaching

1.8

35.7

683

4028

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

35.6

512

2727

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

35.3

548

3005

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

59.0

35.2

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.1

34.7

402

1958

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.1

34.5

138

342

L88

ICPC

Rheumatoid/seropositive arthritis

2.8

34.4

226

819

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

19.4

34.3

GX1D5

NOMESCO Finland

Flow volume spirometry

39.4

34.3

J43.8

ICD-10 Finland

Other emphysema

15.9

33.7

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

33.7

595

3411

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.5

33.6

139

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

33.5

557

3129

M34.1

ICD-10 Finland

CR(E)ST syndrome

14.5

33.1

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.5

33.0

119

267

J94.1

ICD-10 Finland

Fibrothorax

74.6

32.8

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

32.8

364

1741

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

32.8

1439

10558

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

32.4

625

3687

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.9

32.1

136

355

JN4BD

NOMESCO Finland

Extensive body CT

1.8

31.8

625

3707

XX9XE

NOMESCO Finland

Other ultrasound examination

6.9

31.7

117

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

22.1

31.7

L04AA01

ATC

[U] ciclosporin; systemic

4.5

31.4

115

262

M05BA07

ATC

risedronic acid; oral

2.8

31.2

211

779

E0000UV

ATC

1.5

31.0

1734

13345

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

30.9

370

1827

J01DB01

ATC

cefalexin; oral

1.5

30.8

3773

33617

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

30.6

942

6347

M01CB01

ATC

sodium aurothiomalate; parenteral

4.3

30.3

114

267

F1246

NOMESCO Finland

18.5

30.0

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

29.8

165

534

D07AC01

ATC

betamethasone; topical

1.5

29.8

1583

12036

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

6.9

29.7

110

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

29.7

266

1149

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

23.5

29.6

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

29.5

388

1991

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

29.2

256

1093

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

4.1

29.2

116

287

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.7

28.9

100

216

N03AX16

ATC

pregabalin; oral

1.5

28.8

1068

7507

J20

ICD-10 Finland

Acute bronchitis

1.9

28.8

444

2421

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.1

28.8

101

G47.3

ICD-10 Finland

Sleep apnoea

1.6

28.7

967

6649

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

33.9

28.7

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

29.4

28.5

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.8

28.4

A03

ICPC

Fever

1.8

28.2

573

3430

N02BE01

ATC

paracetamol; systemic, rectal

1.5

28.0

4150

37906

J01FA15

ATC

telithromycin; oral

1.9

27.9

418

2253

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.6

27.9

128

359

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

27.8

275

1247

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

15.1

27.2

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.3

27.2

A02BC03

ATC

lansoprazole; oral

1.4

27.1

1421

10731

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

9.1

27.1

H02AB04

ATC

methylprednisolone; systemic

1.7

27.0

683

4356

2AX04

NOMESCO Finland

62.3

26.9

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

26.8

1431

10841

Z51.5

ICD-10 Finland

Palliative care

2.0

26.8

370

1936

R06.2

ICD-10 Finland

Wheezing

2.4

26.7

226

949

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

26.5

702

4532

R06AE07

ATC

cetirizine; oral

1.4

26.3

1722

13542

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

26.3

332

1676

XJC10

NOMESCO Finland

Oesophageal pH monitoring

8.2

26.2

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

26.0

524

3127

WX872

NOMESCO Finland

Intensive care

2.1

25.9

296

1432

J01FF01

ATC

clindamycin; systemic

1.5

25.6

1237

9171

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

25.3

1246

9270

J96.0

ICD-10 Finland

Acute respiratory failure

3.8

25.3

110

296

RS123

NOMESCO Finland

35.8

25.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

25.1

1680

13233

WX722

NOMESCO Finland

PEEP

2.2

25.1

271

1277

WX726

NOMESCO Finland

High-flow oxygen therapy

20.7

25.1

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.1

887

6144

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

F2680

NOMESCO Finland

14.7

24.7

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

24.5

179

693

L04AB01

ATC

etanercept; parenteral

4.6

24.4

186

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.5

24.1

197

812

XG460

NOMESCO Finland

Short time oxymetry

3.2

24.0

131

421

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

24.0

1899

15368

3A006

NOMESCO Finland

+∞

24.0

M04AA01

ATC

allopurinol; systemic

1.6

23.9

789

5372

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.8

23.5

J45.8

ICD-10 Finland

Mixed asthma

2.7

23.4

164

619

A01AB09

ATC

miconazole; local oral

1.8

23.4

432

2501

L04AB04

ATC

adalimumab; parenteral

4.0

23.2

233

L01AA01

ATC

cyclophosphamide; systemic

7.2

23.2

J01FA09

ATC

clarithromycin; systemic

1.4

23.0

1225

9226

JN4AD

NOMESCO Finland

Body CT examination

1.8

23.0

407

2327

WX110

NOMESCO Finland

Local anesthesy

1.3

22.9

2867

24886

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

22.9

123

391

B01AA03

ATC

warfarin; systemic

1.4

22.8

1249

9451

UJF32

NOMESCO Finland

Coloscopy

1.4

22.6

1266

9617

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

22.5

295

1513

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.2

22.4

212

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

22.3

1530

12051

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

22.3

226

1036

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

22.2

414

2405

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

21.9

Z57.2

ICD-10 Finland

Occupational exposure to dust

8.1

21.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

21.8

494

3045

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.3

21.7

111

341

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

80.4

21.7

N02AA05

ATC

oxycodone; systemic

1.5

21.6

781

5420

J43.2

ICD-10 Finland

Centrilobular emphysema

8.5

21.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

21.5

665

4451

R03AK11

ATC

formoterol and fluticasone; inhalant

3.0

21.5

129

441

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.0

21.5

216

XG405

NOMESCO Finland

Education on PEF monitoring

3.6

21.4

281

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

21.2

720

4926

SPAT1262

SPAT

Handing over of treatment supplies

1.5

21.1

929

6720

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

21.1

205

921

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

21.0

745

5142

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

21.0

300

1591

AN1

Coronary angiography

1.5

20.9

717

4912

5AB14

NOMESCO Finland

17.9

20.8

M34.0

ICD-10 Finland

Progressive systemic sclerosis

24.3

20.8

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

20.8

234

1127

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.1

20.8

J05AB11

ATC

valaciclovir; oral

1.6

20.8

545

3498

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

20.6

1351

10525

SPAT1325

SPAT

Vaccination

1.3

20.4

1740

14145

GAA31

NOMESCO Finland

Thoracoscopy

8.2

20.4

J80

ICD-10 Finland

Adult respiratory distress syndrome

7.6

20.3

WZA10

NOMESCO Finland

Long statement of health and health related matters

4.0

20.2

209

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

20.2

332

1851

J99.0

ICD-10 Finland

Rheumatoid lung disease

48.2

20.1

SPAT1263

SPAT

Sampling

1.3

19.6

1894

15675

L04AA24

ATC

abatacept; parenteral

9.4

19.5

J12.8

ICD-10 Finland

Other viral pneumonia

5.2

19.3

117

120

Kela drug reimbursment

Hypogammaglobulinaemia

15.6

19.2

M33.2

ICD-10 Finland

Polymyositis

11.7

19.2

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.7

19.1

140

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.9

19.1

127

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

8.6

19.1

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.8

19.0

126

462

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

19.0

1191

9189

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

18.9

373

2203

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

18.9

1239

9629

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

5.5

18.8

100

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.9

18.6

R01AD12

ATC

fluticasone furoate; nasal

1.4

18.6

961

7158

XQ800

NOMESCO Finland

Prick test

2.0

18.5

241

1232

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.3

18.5

163

R03AC03

ATC

terbutaline; inhalant

1.6

18.5

573

3827

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.8

18.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

18.5

519

3386

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

18.3

288

1578

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.3

18.2

276

ZXA10

NOMESCO Finland

Bilateral

1.4

18.2

889

6544

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

17.6

18.2

C01DA14

ATC

isosorbide mononitrate; oral

1.4

18.2

986

7404

RK320

NOMESCO Finland

4.0

18.2

185

XPX04

NOMESCO Finland

Angioscopy

10.4

18.1

I73.0

ICD-10 Finland

Raynaud syndrome

3.8

17.9

197

M05BX04

ATC

denosumab; parenteral

1.9

17.8

252

1333

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

17.7

1134

8761

J46

ICD-10 Finland

Status asthmaticus

2.6

17.7

133

526

5BA08

NOMESCO Finland

6.0

17.6

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.8

17.6

121

WX002

NOMESCO Finland

Sedation and analgesia

1.4

17.6

923

6884

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

14.6

17.6

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

17.5

135

540

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

17.5

279

1540

R03BB01

ATC

ipratropium bromide; inhalant

1.9

17.3

249

1324

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

17.2

116

431

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.4

17.1

J01DA01

ATC

[U] cefalexin; systemic

1.3

17.1

2783

24583

J01MA02

ATC

ciprofloxacin; systemic

1.3

17.0

1866

15631

R01AD09

ATC

mometasone; nasal

1.3

17.0

1651

13593

RK110

NOMESCO Finland

4.3

17.0

144

GX2C5

NOMESCO Finland

Short-lasting oximetry

16.0

17.0

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

16.9

109

394

M33.1

ICD-10 Finland

Other dermatomyositis

17.4

16.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

16.8

412

2591

D07AC13

ATC

mometasone; topical

1.4

16.8

1215

9564

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

16.8

320

1872

J18

ICD-10 Finland

Pneumonia, organism unspecified

4.5

16.7

133

C03DA01

ATC

spironolactone; oral

1.5

16.6

561

3821

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

15.1

16.6

M10.9

ICD-10 Finland

Gout, unspecified

1.7

16.4

368

2256

ZXA00

NOMESCO Finland

Right side

1.3

16.4

1295

10334

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

4.2

16.4

145

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

16.3

141

602

M25.5

ICD-10 Finland

Pain in joint

1.4

16.3

1048

8090

N02AA01

ATC

morphine; systemic, rectal

3.0

16.3

317

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

16.2

361

2212

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

16.2

197

981

C09AA05

ATC

ramipril; oral

1.3

16.1

1329

10663

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

30.1

16.1

R03AC12

ATC

salmeterol; inhalant

1.9

15.9

239

1289

N05CF01

ATC

zopiclone; oral

1.3

15.9

1520

12459

E000001

ATC

1.4

15.9

830

6177

B02.9

ICD-10 Finland

Zoster without complication

1.8

15.9

282

1613

M35.1

ICD-10 Finland

Other overlap syndromes

5.8

15.8

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

15.8

114

441

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

15.8

238

1287

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

15.8

1250

9966

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

15.7

1026

7931

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

+∞

15.6

AK3

BLTX (both lung transplants)

+∞

15.6

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.4

15.5

129

538

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

13.7

15.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.8

15.5

100

363

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

15.4

629

4458

R03DA04

ATC

theophylline; systemic, rectal

1.7

15.4

308

1829

D07AB08

ATC

desonide; topical

1.6

15.4

435

2839

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

5.1

15.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

15.3

392

2494

A28

ICPC

Limited function/disability NOS

1.4

15.2

821

6136

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

15.2

245

1359

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

15.2

122

503

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

9.2

15.1

SPAT1255

SPAT

Intravenous administration of medicine

1.7

15.1

310

1854

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.0

15.1

152

M05.1

ICD-10 Finland

Rheumatoid lung disease

45.1

15.0

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

45.1

15.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

15.0

297

1758

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

14.9

486

3281

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

14.9

163

779

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.0

14.9

194

996

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

14.8

498

3386

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

14.8

150

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.7

14.8

104

318

Kela drug reimbursment

Teriparatide

5.8

14.8

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

14.7

459

3066

1CX01

NOMESCO Finland

11.3

14.7

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

14.6

358

2253

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.2

14.6

133

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

14.4

348

2177

1XC02

NOMESCO Finland

4.3

14.4

125

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

14.4

232

J02AC01

ATC

fluconazole; systemic

1.3

14.3

1333

10852

N03AX12

ATC

gabapentin; oral

1.4

14.2

638

4603

J67.0

ICD-10 Finland

Farmer lung

9.1

14.2

D07XC01

ATC

betamethasone, combinations; topical

1.5

14.1

524

3637

XF402

NOMESCO Finland

ECG with work load test

1.5

14.1

559

3937

R03AC13

ATC

formoterol; inhalant

1.8

14.1

233

1301

R4190

NOMESCO Finland

Nutritional therapy

2.2

14.0

137

623

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

14.4

14.0

1240

FHL

Bronchoscopy

3.0

14.0

275

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

13.8

158

770

R29

ICPC

Respiratory symptom/complaint other

1.8

13.8

254

1470

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.3

13.8

117

B01AB05

ATC

enoxaparin; parenteral

1.3

13.7

1391

11450

J98.4

ICD-10 Finland

Other disorders of lung

9.7

13.7

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

13.6

1333

10918

R74

ICPC

Upper respiratory infection acute

1.4

13.6

802

6081

R01AD08

ATC

fluticasone; nasal

1.3

13.6

1023

8070

M79.6

ICD-10 Finland

Pain in limb

1.3

13.5

1444

11961

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

140.3

13.4

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

140.3

13.4

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.5

13.4

106

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

13.4

210

1154

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

25.8

13.3

4040

NOMESCO Finland

21.2

13.3

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

13.2

1899

16314

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.1

13.2

230

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

13.2

339

2159

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.2

13.2

214

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.4

13.2

182

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

13.2

108

450

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

13.2

143

682

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.2

1405

11628

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

13.1

168

858

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

13.1

165

838

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.0

1371

11322

J42

ICD-10 Finland

Unspecified chronic bronchitis

3.0

13.0

244

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

13.0

528

3737

TGD00

NOMESCO Finland

Needle biopsy of lung

4.7

13.0

R2110

NOMESCO Finland

Giving the first information

1.8

12.9

243

1414

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

28.4

12.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

12.9

350

2259

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

12.9

223

1267

ZXA05

NOMESCO Finland

Left side

1.3

12.9

1188

9635

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

11.5

12.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

12.7

832

6412

J94.8

ICD-10 Finland

Other specified pleural conditions

2.5

12.7

377

R4120

NOMESCO Finland

Occupational therapy

1.7

12.6

263

1583

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.2

12.5

206

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

12.5

304

Kela drug reimbursment

Dornase alfa

+∞

12.5

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

12.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

12.5

1360

11273

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

10.0

12.4

H02AB09

ATC

hydrocortisone; systemic

2.4

12.4

100

413

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

12.4

321

2048

L04AA17

ATC

[U] adalimumab; parenteral

7.6

12.4

H05AA02

ATC

teriparatide; parenteral

5.4

12.3

J93.8

ICD-10 Finland

Other pneumothorax

4.8

12.3

R05FB02

ATC

cough suppressants and expectorants

1.3

12.3

1667

14187

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.1

12.3

134

639

GX2D5

NOMESCO Finland

Sleep oximetry

6.5

12.3

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

12.2

839

6508

I27.0

ICD-10 Finland

Primary pulmonary hypertension

8.4

12.2

J02AC03

ATC

voriconazole; systemic

9.0

12.2

291

Kela drug reimbursment

Tofacitinib

9.6

12.2

J45

ICD-10 Finland

Asthma

1.6

12.1

361

2383

WX882

NOMESCO Finland

High dependency care

2.0

12.1

143

708

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

12.0

325

2099

A46

ICD-10 Finland

Erysipelas

1.4

12.0

664

4974

M54.5

ICD-10 Finland

Low back pain

1.3

12.0

1234

10146

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.5

11.9

359

2378

Angiography of the heart and coronary arteries

1.5

11.9

393

2659

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

11.8

597

4402

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

11.7

276

1719

L04AC07

ATC

tocilizumab; parenteral

8.9

11.7

J01GB01

ATC

tobramycin; inhalant, parenteral

16.4

11.6

A02BA03

ATC

famotidine; systemic

1.8

11.6

199

1128

M05BA06

ATC

ibandronic acid; systemic

2.4

11.6

398

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

4.5

11.6

J05AB01

ATC

aciclovir; systemic

1.3

11.6

801

6223

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.5

11.5

362

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

11.5

517

3729

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.1

11.5

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.3

11.4

171

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.9

11.4

115

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

6.3

11.3

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.5

11.3

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.5

11.2

147

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

11.2

1343

11239

C10AA03

ATC

pravastatin; oral

1.5

11.1

369

2500

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

11.1

276

1744

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

20.1

11.1

M31.3

ICD-10 Finland

Wegener granulomatosis

4.9

11.1

EBA15

NOMESCO Finland

Extraction of large number of teeth

1.8

11.0

175

967

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

5.6

11.0

L01CB

ATC

Podophyllotoxin derivatives

7.4

10.9

RS230

NOMESCO Finland

5.0

10.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

10.9

234

1424

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

10.8

101

452

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

10.7

363

2472

D02AE01

ATC

carbamide; topical

1.6

10.7

256

1602

S18

ICPC

Laceration/cut

1.2

10.7

1885

16453

R24

ICPC

Haemoptysis

3.9

10.7

112

NG1DA

NOMESCO Finland

X-ray of knees

2.4

10.7

357

A01AB04

ATC

amphotericin B; local oral

1.7

10.7

222

1335

L03

ICPC

Low back symptom/complaint

1.3

10.7

897

7162

WX402

NOMESCO Finland

General anaesthesia

1.4

10.6

597

4481

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

7.5

10.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

10.6

285

1839

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.8

10.6

113

6BA02

NOMESCO Finland

8.0

10.6

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

10.5

180

1019

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

10.5

245

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

10.5

128

643

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

10.5

1644

14165

J01FA01

ATC

erythromycin; systemic

1.4

10.5

429

3041

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.0

10.5

100

A91

ICPC

Abnormal result investigation NOS

1.8

10.5

174

979

M01CB03

ATC

auranofin; oral

3.5

10.5

135

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.2

10.4

167

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

10.4

697

5380

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.9

10.4

105

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

10.4

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.8

10.4

233

R03AC19

ATC

olodaterol; inhalant

4.4

10.4

XF404

NOMESCO Finland

Ambulatory ECG

1.4

10.3

426

3022

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

16.0

10.3

Z94.3

ICD-10 Finland

Heart and lungs transplant status

32.6

10.3

SPAT1260

SPAT

Consultation of another employee

1.3

10.3

760

5953

Z71.8

ICD-10 Finland

Other specified counselling

1.3

10.3

844

6712

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.3

1034

8453

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

10.3

301

S97

ICPC

Chronic ulcer skin

1.6

10.3

265

1691

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

18.8

10.2

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

7.1

10.2

I50.1

ICD-10 Finland

Left ventricular failure

1.6

10.2

254

1607

L95

ICPC

Osteoporosis

2.0

10.2

130

665

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.8

10.2

221

ED1AA

NOMESCO Finland

Mandipular X-ray examination

4.1

10.2

A02BA02

ATC

ranitidine; systemic

1.3

10.2

918

7396

R03BB07

ATC

umeclidinium bromide; inhalant

3.4

10.1

144

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

10.0

404

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.1

10.0

104

492

N07BA03

ATC

varenicline; oral

1.8

10.0

153

840

H26.3

ICD-10 Finland

Drug-induced cataract

4.2

9.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

9.9

354

2437

A04

ICPC

Weakness/tiredness general

1.4

9.9

522

3874

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.3

9.9

411

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

9.9

223

1376

R95

ICPC

Chron obstructive pulmonary disease

1.9

9.8

136

719

C02KX01

ATC

bosentan; oral

26.0

9.8

TK800

NOMESCO Finland

Hemodialysis

2.1

9.7

102

483

RK250

NOMESCO Finland

4.2

9.7

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.6

9.7

268

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.7

1556

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

9.7

595

4529

B59

ICD-10 Finland

Pneumocystosis

13.4

9.7

WX720

NOMESCO Finland

Own respiration

1.8

9.6

161

906

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.6

883

7122

XA421

NOMESCO Finland

Nocturnal polygraphy

5.8

9.6

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.2

9.6

L04AA29

ATC

tofacitinib; oral

7.8

9.6

RS220

NOMESCO Finland

2.8

9.6

207

B01AC04

ATC

clopidogrel; oral

1.3

9.6

836

6702

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

9.5

489

3611

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.3

9.5

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

4.1

9.5

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

9.5

2300

20656

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

9.1

9.5

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

9.4

113

563

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.6

9.4

250

ZX114

NOMESCO Finland

Intramuscular

2.6

9.4

250

SBA10

NOMESCO Finland

Measurement of excretion of saliva

3.3

9.4

142

L04AB05

ATC

certolizumab pegol; parenteral

6.6

9.4

WW500

NOMESCO Finland

Blood transfusion

1.8

9.4

170

984

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.2

9.4

391

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

+∞

9.4

4038

NOMESCO Finland

+∞

9.4

ZX197

NOMESCO Finland

12.3

9.3

D72.1

ICD-10 Finland

Eosinophilia

5.3

9.3

E000003

ATC

1.7

9.3

171

993

N18.8

ICD-10 Finland

Other chronic renal failure

1.8

9.3

149

829

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.2

9.3

439

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

9.3

133

710

293

Kela drug reimbursment

Baricitinib

10.7

9.3

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

10.7

9.3

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.3

9.3

133

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

9.2

356

2493

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.4

9.2

-1

NOMESCO Finland

1.3

9.2

1115

9308

E000002

ATC

1.4

9.2

386

2745

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

9.2

324

2228

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.5

9.2

303

2054

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

9.1

1010

8340

N06AX11

ATC

mirtazapine; oral

1.2

9.1

1234

10434

L57.0

ICD-10 Finland

Actinic keratosis

1.4

9.1

485

3606

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

5.9

9.0

XG430

NOMESCO Finland

Spiroegometry

36.7

9.0

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

36.7

9.0

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

36.7

9.0

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

4.0

9.0

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.5

9.0

275

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.5

8.9

I50

ICD-10 Finland

Heart failure

1.7

8.9

164

957

R06AX27

ATC

desloratadine; oral

1.3

8.9

789

6334

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.9

321

2218

ZX140

NOMESCO Finland

Intra articular

3.4

8.8

117

R53

ICD-10 Finland

Malaise and fatigue

1.3

8.8

841

6815

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

8.8

254

1672

L04AA37

ATC

baricitinib; oral

10.7

8.8

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.3

8.8

329

3006

Kela drug reimbursment

Baricitinib

9.5

8.8

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

9.5

8.8

C08CA05

ATC

nifedipine; systemic

1.5

8.7

324

2253

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

8.7

353

2497

M06

ICD-10 Finland

Other rheumatoid arthritis

3.5

8.7

108

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.7

1482

12834

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.0

8.7

108

552

UDC00

NOMESCO Finland

Ear microscopy

1.5

8.6

292

1991

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

8.6

267

1788

NDG30

NOMESCO Finland

Fusion of wrist, total

3.8

8.6

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.7

8.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

8.6

166

981

L04AA11

ATC

[U] etanercept; parenteral

5.2

8.6

R60.0

ICD-10 Finland

Localized oedema

1.4

8.6

488

3666

Z31.5

ICD-10 Finland

Genetic counselling

1.9

8.6

125

673

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.6

8.6

244

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

8.5

137

766

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

8.5

196

1218

WVA20

NOMESCO Finland

Medicine administration

2.1

8.5

450

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

8.5

2015

17995

RK310

NOMESCO Finland

10.0

8.5

3AC01

NOMESCO Finland

2.8

8.5

182

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

8.5

124

2049

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

8.5

184

1126

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

8.5

1138

9601

J01XB01

ATC

colistin; inhalant, parenteral

20.0

8.5

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

8.4

120

641

AA1AD

NOMESCO Finland

CT of head and brain

1.2

8.4

1110

9343

R03BB06

ATC

glycopyrronium bromide; inhalant

4.0

8.4

L04AB06

ATC

golimumab; parenteral

4.0

8.4

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

8.4

393

2857

RS221

NOMESCO Finland

2.4

8.4

268

R06AX22

ATC

ebastine; oral

1.3

8.4

521

3974

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.4

2734

25116

SBA00

NOMESCO Finland

Microbiological examinations

2.1

8.3

461

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

8.3

1622

14211

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

8.3

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

5.8

8.3

M02AA07

ATC

piroxicam; topical

1.2

8.3

1579

13807

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.3

562

4343

D07AA02

ATC

hydrocortisone; topical

1.4

8.2

470

3534

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

3.0

8.2

146

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

8.2

149

866

M01AH02

ATC

rofecoxib; oral

1.3

8.2

565

4374

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.4

8.2

284

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

8.2

2619

23997

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

14.5

8.2

K76.9

ICD-10 Finland

Liver disease, unspecified

2.6

8.2

214

R03BB05

ATC

aclidinium bromide; inhalant

4.9

8.2

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

6.5

8.2

N06AA09

ATC

amitriptyline; systemic

1.4

8.1

396

2899

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

8.1

441

3287

ZX121

NOMESCO Finland

Central venous catheter

5.1

8.1

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.4

8.1

259

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

8.1

254

1704

132

Kela drug reimbursment

Sarcoidosis

3.1

8.1

131

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.3

8.1

115

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

8.1

107

558

S22.3

ICD-10 Finland

Fracture of rib

1.5

8.1

268

1819

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

33.4

8.1

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.2

8.1

126

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

17.2

8.1

L17

ICPC

Foot/toe symptom/complaint

1.2

8.1

999

8348

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.7

8.0

166

1003

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

8.0

364

SPAT1059

SPAT

Spirometry at the office

1.6

8.0

213

1375

D11

ICPC

Diarrhoea

1.4

8.0

323

2284

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

22.0

8.0

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.0

8.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.0

864

7105

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

8.0

128

716

F03

ICD-10 Finland

Unspecified dementia

0.5

8.0

1466

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

7.9

155

921

M60.9

ICD-10 Finland

Myositis, unspecified

4.1

7.9

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

7.9

158

945

B01AB04

ATC

dalteparin; parenteral

1.6

7.9

213

1381

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.2

7.8

330

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.2

7.8

364

XX7LW

NOMESCO Finland

5.7

7.8

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

4.3

7.8

C02KX04

ATC

macitentan; oral

10.8

7.8

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

7.8

224

1475

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

7.7

439

R06AE09

ATC

levocetirizine; oral

1.4

7.7

424

3173

A07EC02

ATC

mesalazine; oral, rectal

1.6

7.7

184

1160

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.6

1703

15087

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.3

7.6

FXE00

NOMESCO Finland

Use of ECLA

18.4

7.6

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

18.4

7.6

L08

ICPC

Shoulder symptom/complaint

1.3

7.6

724

5863

J98.2

ICD-10 Finland

Interstitial emphysema

8.0

7.6

B01AF02

ATC

apixaban; oral

1.3

7.6

471

3590

N19

ICD-10 Finland

Unspecified kidney failure

1.6

7.6

165

1013

A02BA04

ATC

nizatidine; systemic

1.4

7.6

354

2572

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

25.0

7.6

J17.3

ICD-10 Finland

Pneumonia in parasitic diseases

25.0

7.6

B37.0

ICD-10 Finland

Candidal stomatitis

2.8

7.5

167

M01AB55

ATC

diclofenac, combinations; oral

1.4

7.5

300

2115

R04.0

ICD-10 Finland

Epistaxis

1.4

7.5

336

2424

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

10.0

7.5

L28

ICPC

Limited function/disability (L)

1.3

7.5

718

5821

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

4.0

7.4

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.0

7.4

447

S29

ICPC

Skin symptom/complaint other

1.3

7.4

668

5370

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.2

7.4

118

R96

ICPC

Asthma

1.4

7.4

322

2312

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.3

7.4

288

3005

Kela drug reimbursment

Tofacitinib

7.6

7.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.9

7.4

151

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.3

7.4

269

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.5

7.3

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

7.3

246

1679

K29.7

ICD-10 Finland

Gastritis, unspecified

1.7

7.3

144

860

ZX100

NOMESCO Finland

Oral

2.2

7.3

335

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

XX4AW

NOMESCO Finland

6.8

7.3

S22.2

ICD-10 Finland

Fracture of sternum

3.5

7.3

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

7.2

426

3220

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

15.7

7.2

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

15.7

7.2

J01DA06

ATC

[U] cefuroxime; systemic

1.3

7.2

531

4155

UJD02

NOMESCO Finland

Gastroscopy

1.5

7.1

205

1350

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.1

899

7517

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.7

7.1

137

813

207

Kela drug reimbursment

Chronic arrhythmias

1.3

7.1

753

6169

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.1

7.1

354

R13

ICD-10 Finland

Dysphagia

1.5

7.1

268

1872

D07AD01

ATC

clobetasol; topical

1.3

7.1

576

4565

J92

ICD-10 Finland

Pleural plaque

7.9

7.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.1

915

7670

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.8

7.1

150

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.0

7.1

A06AD11

ATC

lactulose; oral

1.3

7.0

692

5623

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

7.0

410

3103

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.4

6.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

6.9

318

2304

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.7

6.9

159

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.8

6.9

153

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.9

990

8393

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

6.9

337

4447

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

6.9

286

2038

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

6.9

166

1047

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.9

1996

18046

3A064

NOMESCO Finland

3.8

6.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.8

426

3253

1243

FHL

Bronchoscopy and other therapeutic procedure

8.3

6.8

5823

FHL

Lung avobiopsy and wedge resection

8.3

6.8

B01AB10

ATC

tinzaparin; parenteral

1.4

6.8

271

1915

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.8

6.8

142

K07

ICPC

Swollen ankles/oedema

1.5

6.8

195

1284

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.3

6.8

-44

ICPC

Preventive immunization/medic

1.4

6.8

367

2739

JN4CD

NOMESCO Finland

Very extensive body CT

1.6

6.8

170

1085

M10

ICD-10 Finland

Gout

1.5

6.8

204

1360

M01CC01

ATC

penicillamine; oral

6.1

6.8

XV5WT

NOMESCO Finland

40.1

6.8

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

40.1

6.8

B07.9

ICD-10 Finland

Verruca simplex

1.8

6.7

104

575

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.7

6.7

156

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.5

6.7

209

1402

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.0

6.7

116

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.5

6.7

199

R49.01

ICD-10 Finland

Functional dysphonia

1.8

6.7

100

548

GD1LA

NOMESCO Finland

2.2

6.7

301

NDG74

NOMESCO Finland

Fusion of first IP joint

4.7

6.7

UDM02

NOMESCO Finland

Sinoscopy

2.0

6.7

397

TNG10

NOMESCO Finland

Puncture of knee

2.4

6.7

211

A11

ICPC

Chest pain NOS

1.4

6.6

299

2160

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

6.6

386

J98.1

ICD-10 Finland

Pulmonary collapse

3.1

6.6

106

M54

ICD-10 Finland

Dorsalgia

1.4

6.6

355

2643

C10AA01

ATC

simvastatin; oral

1.2

6.6

2253

20608

RD210

NOMESCO Finland

2.2

6.6

271

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.2

6.6

283

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

6.6

321

4236

I20.09

ICD-10 Finland

Unstable angina

1.4

6.6

278

1984

L01BB01

ATC

5.1

6.6

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

6.6

176

1141

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.3

6.6

232

GDC00

NOMESCO Finland

Lobectomy of lung

2.9

6.6

132

602

Kela drug reimbursment

Children's severe malnutrition

12.2

6.6

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.4

6.6

225

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.6

213

1443

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

6.5

354

2642

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

6.5

557

4443

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.2

6.5

298

T90

ICPC

Diabetes non-insulin dependent

1.2

6.5

1041

8914

C10AA05

ATC

atorvastatin; oral

1.2

6.5

1826

16439

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

6.5

315

2306

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

4.3

6.5

P70

ICPC

Dementia

0.4

6.5

609

RJ412

NOMESCO Finland

6.8

6.5

WNF00

NOMESCO Finland

Infection source and contact determination

3.4

6.5

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

6.5

300

A01

ICPC

Pain general/multiple sites

1.4

6.5

283

2035

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.5

1614

14393

N06DA02

ATC

donepezil; oral

0.6

6.4

125

1935

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

69.9

6.4

M34

ICD-10 Finland

Systemic sclerosis

69.9

6.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

6.4

1294

11327

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

6.4

103

578

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

14.3

6.4

H01

ICPC

Ear pain/earache

1.4

6.4

298

2169

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.5

6.4

193

1290

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

6.4

1592

14195

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.1

6.4

104

N30.2

ICD-10 Finland

Other chronic cystitis

2.7

6.4

144

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

6.3

568

4562

M01AH05

ATC

etoricoxib; oral

1.2

6.3

2197

20099

M32

ICD-10 Finland

Systemic lupus erythematosus

11.0

6.3

J01AA07

ATC

tetracycline; systemic

1.3

6.3

441

3427

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

4.6

6.3

D68.8

ICD-10 Finland

Other specified coagulation defects

2.9

6.3

125

GDB01

NOMESCO Finland

Thoracoscopic resection of bullae of lung

18.0

6.3

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

18.0

6.3

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

6.3

303

2220

J86.9

ICD-10 Finland

Pyothorax without fistula

2.4

6.3

199

C01AA05

ATC

digoxin; systemic

1.3

6.2

438

3404

M33

ICD-10 Finland

Dermatopolymyositis

+∞

6.2

6BB16

NOMESCO Finland

+∞

6.2

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.8

6.2

133

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.2

716

5918

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.9

6.2

445

M79.1

ICD-10 Finland

Myalgia

1.3

6.2

402

3088

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

4.3

6.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.9

6.2

418

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.2

2707

25184

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.6

6.2

146

918

WX730

NOMESCO Finland

Conventional respirator

2.0

6.2

367

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.7

6.2

141

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.6

6.2

XJC00

NOMESCO Finland

Oesophageal manometry

3.8

6.2

HA1AA

NOMESCO Finland

X-ray mammography

1.5

6.1

227

1584

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

6.1

565

SPAT1060

SPAT

Administration of oxygen

3.3

6.1

N06AX16

ATC

venlafaxine; oral

1.3

6.1

381

2908

L03AA02

ATC

filgrastim; parenteral

1.8

6.1

106

610

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

7.7

6.1

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

6.1

377

2876

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.1

113

664

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.2

6.1

266

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

12.5

6.1

XX1VW

NOMESCO Finland

Written report from radiologist

2.8

6.1

130

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.4

6.0

248

1762

J43.1

ICD-10 Finland

Panlobular emphysema

6.7

6.0

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

6.0

100

571

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

6.0

183

1226

N06DA03

ATC

rivastigmine; oral, transdermal

0.6

6.0

1206

J01DA08

ATC

[U] cefaclor; oral

1.4

6.0

282

2057

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.2

6.0

249

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

784

1809

4.85

318.59

1.8

u/l

38.4

38.3

0.06

713

1542

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

613

1144

5.87

316.92

1.8

1.4

g/l

0.2

2.87

588

1078

(3003396) Base excess in Arterial blood by calculation

1636

6309

3.22

316.65

9.2

6.8

mmol/l

1.4

1.1

2.72

1357

4852

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

616

1185

5.70

308.07

1.8

1.4

g/l

1.2

1.15

594

1113

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

582

759

8.41

307.65

1.3

1.2

u/ml

19.4

2.4

1.82

(44790047)

440

480

9.84

307.65

2.7

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4405

26882

3.64

307.65

15.5

8.6

e9/l

4.7

4.3

28.03

4086

23246

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1295

1828

8.83

307.65

3.2

2.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

608

932

7.17

307.65

1.4

1.2

titre

177.3

141.2

0.11

(3037522) Nuclear Ab [Titer] in Serum

2234

5191

6.37

307.65

1.5

1.3

titre

604.3

505.8

1.49

677

1094

(3037692) Legionella sp identified in Specimen by Organism specific culture

328

136

25.50

307.65

2.0

1.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

778

1279

6.87

307.65

1.7

1.4

iu/ml

11.4

16.7

0.49

(3018010) Neutrophils/100 leukocytes in Blood

4034

21840

3.77

307.65

12.1

5.7

60.4

58.3

22.99

3941

20176

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

579

623

10.21

307.65

1.8

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

738

289

29.11

307.65

2.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

561

847

7.22

307.65

12.4

4.4

iu/ml

1533.1

2324.4

0.14

131

115

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

612

707

9.56

307.65

1.8

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

824

783

12.10

307.65

2.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

552

639

9.44

307.65

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

861

1401

7.04

307.65

1.3

1.2

u/ml

2.0

0.8

1.18

131

(3006504) Eosinophils/100 leukocytes in Blood

4068

21688

3.92

307.65

12.5

5.7

2.7

2.9

4.29

3978

20012

(44806118)

440

480

9.84

307.65

2.7

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

887

1143

8.98

307.65

2.4

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

624

918

7.50

307.65

1.4

1.2

u/ml

7.8

2.8

0.84

(3002030) Lymphocytes/100 leukocytes in Blood

4078

22197

3.81

307.65

12.7

5.9

24.6

26.4

20.91

3986

20401

(44790048)

440

480

9.84

307.65

2.7

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2164

8958

3.26

307.65

2.8

1.8

—

(3019069) Monocytes/100 leukocytes in Blood

4074

21795

3.91

307.65

12.9

6.1

8.9

0.04

3986

20172

(3006184) Hemoglobin [Mass/volume] in Capillary blood

687

1208

6.32

307.65

2.4

2.2

g/l

128.7

127.6

0.31

269

915

(44790049)

440

480

9.84

307.65

2.7

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

559

695

8.79

307.65

1.5

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1714

6159

3.53

307.65

2.6

1.7

—

(3000492) Spirometry study

1214

3639

3.95

307.65

2.9

1.4

—

(3001604) Monocytes [#/volume] in Blood

4302

22999

4.36

307.65

11.7

5.4

e9/l

0.7

0.6

21.19

3932

19518

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

706

638

12.46

307.65

2.1

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1651

6328

3.25

307.65

9.2

6.8

kpa

10.2

12.1

59.32

1590

6001

(3013115) Eosinophils [#/volume] in Blood

4371

23872

4.36

307.65

12.4

5.6

e9/l

0.2

2.59

4044

20571

(3042631) Mycobacterium sp identified in Specimen

585

724

8.87

307.65

3.1

2.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

441

163

29.20

307.65

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

982

1542

7.46

307.65

1.8

1.6

titre

283.3

230.8

0.27

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

874

1093

9.24

307.65

2.4

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1653

6330

3.25

307.65

9.2

6.8

kpa

5.0

5.1

0.93

1590

6006

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1718

6138

3.55

307.65

2.6

1.8

—

(4010399)

1139

3247

4.12

307.65

2.0

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1293

3247

4.84

307.65

4.1

2.7

g/l

10.3

10.5

0.62

1232

2933

(3028026) IgM [Mass/volume] in Serum or Plasma

1009

2565

4.55

307.65

2.2

1.9

g/l

1.1

1.4

3.48

936

2283

(3006315) Basophils [#/volume] in Blood

4311

23140

4.35

307.65

11.7

5.4

e9/l

0.0

5.75

3948

19672

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1983

6635

4.02

307.65

1.4

1.3

iu/ml

56.8

36.7

4.11

692

2012

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1831

6237

3.83

307.65

1.3

1.2

u/ml

29.2

13.2

2.65

530

2267

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

699

848

9.23

307.65

2.4

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

685

782

9.80

307.65

1.2

u/ml

45.6

0.6

—

(3019198) Lymphocytes [#/volume] in Blood

4319

23541

4.26

307.65

11.9

5.5

e9/l

1.9

0.05

3983

20320

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

540

551

10.70

307.65

2.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

627

930

7.44

307.65

1.4

1.2

u/ml

12.8

6.4

1.19

140

141

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1327

1965

8.46

307.65

1.6

u/ml

16.8

17.3

0.02

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

747

1129

7.45

307.65

1.9

1.6

—

(3023419) Bacteria identified in Sputum by Culture

634

608

11.58

307.65

2.7

2.4

—

(3019060) Gas panel - Arterial blood

1277

3687

4.16

307.65

4.8

4.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1039

1100

11.29

307.65

1.9

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

594

663

9.87

307.65

2.4

1.5

—

(3022096) Basophils/100 leukocytes in Blood

4037

21100

4.00

307.65

12.4

5.8

0.6

0.7

2.82

3955

19488

(42870588) Differential panel, method unspecified - Blood

3471

16248

3.82

307.65

11.5

5.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

638

991

7.11

307.65

1.4

1.2

u/ml

41.3

46.7

0.14

(3005322) IgE [Units/volume] in Serum or Plasma

868

2238

4.38

306.11

1.6

1.2

u/ml

254.3

234.3

0.24

808

2030

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

413

527

8.36

305.11

3.5

3.6

—

(3023368) Bacteria identified in Blood by Culture

2814

15217

2.65

281.62

6.1

4.4

—

(3000494) Fungus identified in Specimen by Culture

1405

5311

3.17

277.24

2.3

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

208

107

20.12

269.82

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

308

328

9.86

261.77

2.0

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

1169

4086

3.33

261.60

5.8

3.9

0.8

1.0

0.93

425

1234

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

284

282

10.54

253.82

2.1

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

283

280

10.57

253.57

2.1

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

190

20.64

249.46

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

190

20.64

249.46

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

190

20.64

249.46

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

190

20.64

249.46

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1080

3695

3.36

249.35

5.6

3.7

0.5

0.7

1.12

334

878

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

536

1111

5.21

245.32

1.8

1.9

mg/l

10.8

12.5

1.99

503

1014

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

149

39.18

243.68

3.1

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3877

25695

2.53

235.13

10.0

6.2

umol/l

11.4

12.4

4.95

3765

24335

(3039162) Centromere protein B Ab [Units/volume] in Serum

324

429

7.94

231.29

1.3

1.2

u/ml

59.7

51.0

0.18

(3025159) Blasts/100 leukocytes in Blood

1035

3605

3.28

230.82

5.9

4.0

0.2

0.04

354

959

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

319

421

7.96

228.33

2.1

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

1076

3886

3.17

225.44

5.9

3.9

0.1

1.29

395

1153

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

392

665

6.25

222.18

5.4

2.3

u/ml

694.4

2761.8

1.12

(3016502) Oxygen saturation in Arterial blood

1375

5740

2.83

221.65

10.1

7.1

93.7

95.5

16.46

1331

5511

(3027135) IgG subclass 1 [Mass/volume] in Serum

296

372

8.33

220.69

1.4

1.3

g/l

7.7

6.7

2.04

202

256

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

881

2851

3.46

220.63

10.9

8.8

mmol/l

24.6

24.3

2.44

811

2634

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

396

687

6.11

219.36

1.4

1.2

u/ml

60.4

46.5

0.70

(3028192) IgG subclass 2 [Mass/volume] in Serum

295

372

8.30

219.32

1.4

1.3

g/l

3.0

2.9

0.25

205

259

(3024139) IgG subclass 3 [Mass/volume] in Serum

295

372

8.30

219.32

1.4

1.3

g/l

0.5

0.4

2.09

203

259

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3581

23341

2.39

218.14

9.6

6.1

mmol/l

1.2

4.72

3369

20953

(4062490)

295

375

8.23

217.85

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

319

450

7.44

215.31

2.0

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1210

4795

2.92

214.26

1.5

1.6

—

(3018418) pH of Serum or Plasma

2634

15160

2.35

212.80

5.6

4.1

7.4

0.99

625

2857

(3004616) Nuclear Ab [Presence] in Serum

327

482

7.13

212.07

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

325

480

7.11

210.37

2.0

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

367

619

6.26

209.06

1.6

g/l

0.9

0.06

264

468

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2832

16910

2.32

208.62

4.2

3.2

ng/l

1790.1

1777.0

0.05

2562

14684

(40760892) CBC W Ordered Manual Differential panel - Blood

1848

9265

2.46

202.21

8.9

4.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4609

34260

2.67

201.04

9.7

4.1

mm/h

18.3

13.9

53.28

4492

31229

(3021589) Normoblasts [#/volume] in Blood

3187

20222

2.28

200.03

19.2

10.0

e9/l

0.0

0.73

2735

16397

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

429

882

5.17

197.35

4.6

3.7

59.7

58.2

1.32

429

882

(3042936) Bacteria identified in Isolate by Culture

1540

7184

2.56

195.91

2.6

2.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

251

302

8.64

193.72

1.3

1.1

u/ml

29.1

3.1

1.37

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

255

321

8.26

189.65

1.3

1.1

u/ml

66.2

38.4

0.83

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3746

25729

2.28

189.61

10.5

6.9

mmol/l

1.2

1.38

3135

21579

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

253

320

8.22

187.40

1.3

1.1

u/ml

65.8

82.7

—

(3038026) Centromere Ab [Units/volume] in Serum

256

331

8.04

186.15

1.3

1.1

u/ml

42.3

76.0

0.59

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

232

273

8.81

182.20

4.2

3.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1521

7457

2.41

170.46

1.9

1.5

g/l

2.8

2.6

2.62

1100

4305

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

703

2346

3.27

165.24

2.4

1.9

ug/l

2.3

2.7

0.24

639

2029

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

167

154

11.14

156.65

2.1

1.9

u/ml

61772.4

23010.6

0.26

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1794

9873

2.18

149.49

2.4

1.7

mg/l

1.6

1.4

0.80

1478

7655

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2344

14298

2.07

148.80

5.4

3.2

u/l

34.1

37.0

0.81

2246

13460

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

861

3418

2.78

147.82

5.9

3.8

mmol/l

2.2

1.8

2.68

691

2496

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4685

36970

2.38

147.58

14.6

7.6

u/l

78.6

80.8

2.58

4584

34572

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

346

761

4.77

146.33

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

885

3584

2.73

146.08

6.1

3.8

kpa

5.2

0.03

840

3283

(3009343) pH of Capillary blood

876

3536

2.74

145.48

6.1

3.8

7.4

4.29

154

433

(3011412) CD3 cells [#/volume] in Blood

248

408

6.30

144.33

2.3

2.0

e9/l

1.0

1.1

1.62

176

235

(1616796) Gas panel - Central venous blood

450

1222

3.91

144.33

5.3

3.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

343

759

4.74

143.97

1.3

1.4

u/ml

33.2

14.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1132

5221

2.45

142.43

11.5

7.4

g/l

123.8

120.2

6.35

1095

5029

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

316

660

5.01

142.10

1.4

u/ml

132.2

122.7

0.18

138

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

799

3126

2.80

140.64

12.0

7.0

mmol/l

25.0

24.8

0.89

789

3097

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

444

1216

3.87

140.62

1.6

iu/ml

58.1

5.7

0.91

107

281

(3042733) HLA Ab [Presence] in Serum

129

13.72

138.30

4.2

5.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

931

3971

2.60

137.98

2.2

nmol/l

342.6

375.4

3.84

875

3625

(40758558) Short blood count panel - Blood

2008

11870

2.06

136.05

11.0

6.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

154

156

10.11

135.25

3.6

1.7

ug/l

43.5

60.4

1.46

154

149

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1552

8358

2.17

134.32

6.6

3.1

mmol/l

0.8

0.95

1451

7735

(3001964) Herpes simplex virus Ag [Presence] in Specimen

136

117

11.88

133.45

2.9

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

239

411

6.02

132.94

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

239

411

6.02

132.94

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

239

411

6.02

132.94

1.6

—

(36304419) Bacteria [Presence] in Urine

2236

13828

2.00

132.77

4.7

3.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

669

2452

2.95

132.53

1.3

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

899

3853

2.58

131.48

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

204

304

6.92

130.52

2.2

2.0

16.2

13.9

0.85

125

(1175426) CD3 cells/100 lymphocytes in Blood

207

314

6.80

130.25

2.2

2.0

71.5

71.1

0.10

200

292

(3002582) Erythrocytes [#/volume] in Urine

2453

15786

1.96

128.72

5.0

3.5

e6/l

95.0

108.9

0.11

2006

12371

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

212

335

6.53

128.28

1.4

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3152

22197

1.92

124.76

6.5

4.8

g/l

33.3

34.7

33.34

2944

20464

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

197

297

6.83

124.65

2.3

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

182

252

7.42

124.46

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

182

252

7.42

124.46

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

182

252

7.42

124.46

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

2275

14423

1.95

123.39

4.8

3.3

e6/l

0.4

0.5

0.85

1817

11071

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

255

7.34

123.15

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

182

255

7.34

123.15

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

182

255

7.34

123.15

1.2

1.1

—

(3032080) INR in Blood by Coagulation assay

3129

22069

1.91

122.32

12.7

10.9

inr

1.3

3.61

1055

5985

(3018095) Leukocytes [#/volume] in Urine

2663

17857

1.91

121.30

5.9

3.9

e6/l

101.6

111.2

0.16

2072

13146

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

931

4209

2.44

120.76

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

407

1175

3.65

118.98

3.5

2.5

15.8

16.0

0.32

223

624

(3027315) Oxygen [Partial pressure] in Blood

414

1213

3.60

118.36

6.9

4.5

kpa

8.2

8.4

1.60

405

1183

(3024471) HLA-A [Type]

121

105

11.75

118.03

1.0

—

(3024932) HLA-DR beta [Type]

119

101

12.01

117.74

1.0

1.1

—

(3026782) Osmolality of Urine

1764

10442

1.99

115.23

4.0

2.9

mosm/kgh2o

532.8

554.7

4.85

1582

8878

(3012501) Base excess in Blood by calculation

408

1207

3.56

114.88

6.9

4.5

mmol/l

2.7

0.26

312

817

(3013290) Carbon dioxide [Partial pressure] in Blood

408

1208

3.56

114.73

7.0

4.5

kpa

5.0

0.19

399

1179

(3015235) Bicarbonate [Moles/volume] in Capillary blood

463

1487

3.30

114.53

4.9

3.0

mmol/l

25.3

24.9

1.05

425

1283

(3000850) Epithelial cells [#/volume] in Urine

1857

11224

1.96

113.93

3.9

2.7

e6/l

4.6

4.7

0.08

1688

9843

(3013826) Glucose [Moles/volume] in Serum or Plasma

3848

29432

1.91

112.81

8.7

4.9

mmol/l

6.8

6.9

0.74

3705

27696

(3008152) Bicarbonate [Moles/volume] in Arterial blood

809

3545

2.49

111.74

8.8

6.6

mmol/l

25.1

24.5

4.16

771

3304

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

417

1276

3.44

111.38

3.3

2.4

g/l

3.8

3.6

2.18

406

1208

(3010421) pH of Blood

442

1406

3.32

110.97

6.8

4.3

7.4

1.10

399

1181

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1038

5102

2.26

110.22

4.3

3.0

ng/l

238.2

239.7

0.03

978

4677

(3021901) Oxygen saturation in Capillary blood

377

1088

3.64

110.12

4.6

2.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

198

342

5.96

109.53

2.3

2.0

32.5

41.3

1.12

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

146

183

8.16

108.70

1.5

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

423

1331

3.35

108.02

5.7

3.2

kpa

7.7

8.0

2.36

404

1230

(3020779) Urea [Moles/volume] in Serum or Plasma

1026

5059

2.25

107.91

11.5

6.8

mmol/l

10.7

11.0

0.73

979

4779

(3010375) cycloSPORINE [Mass/volume] in Blood

140

175

8.17

104.46

44.3

23.2

ug/l

156.4

109.6

7.11

115

142

(3023420) DNA double strand Ab [Units/volume] in Serum

201

370

5.59

103.95

1.9

1.2

iu/ml

22.3

24.9

—

(40757373) Influenza virus identified in Isolate

112

108

10.55

101.77

2.9

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1323

7390

2.02

99.66

2.9

2.6

20.7

21.9

2.74

1122

6221

(3022948) Iron [Moles/volume] in Serum or Plasma

1455

8423

1.97

98.87

2.9

2.6

umol/l

11.5

12.3

4.91

1375

7734

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1185

6398

2.07

97.81

4.5

4.0

u/l

269.4

246.2

4.74

1123

6014

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1372

7846

1.98

96.23

2.8

2.5

g/l

2.2

2.3

0.62

1279

7216

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2688

18978

1.78

95.98

2.8

2.2

nmol/l

77.8

79.0

1.42

2472

16605

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

237

546

4.48

94.26

1.3

1.2

u/ml

4.4

3.7

0.11

163

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

389

1263

3.23

94.14

3.4

2.2

89.7

88.5

0.51

373

1199

(3009871) Measles virus Ab [Titer] in Serum

11.74

93.81

1.3

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

434

1513

3.02

92.99

1.7

—

(3000991) Gas panel - Venous blood

909

4518

2.20

92.59

12.2

7.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4084

32787

1.83

91.60

6.8

4.6

—

(4306422)

222

501

4.57

90.60

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

187

367

5.23

90.07

1.4

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1219

6831

1.99

89.86

11.8

6.7

mmol/l

103.9

104.4

3.80

1184

6671

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

218

491

4.57

89.18

1.2

1.1

119.0

114.4

1.04

210

433

(3013293) Extractable nuclear Ab [Presence] in Serum

17.18

88.50

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

147

8.17

88.27

2.2

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

931

4770

2.13

87.39

11.0

6.6

mmol/l

1.5

1.4

1.25

884

4572

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

258

6.06

86.69

1.5

1.3

u/ml

1.5

1.4

0.04

130

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

225

532

4.36

86.53

1.3

1.2

u/ml

3.4

4.9

1.07

135

230

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

250

641

4.03

86.31

1.2

u/ml

344.5

289.0

1.14

163

379

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

174

333

5.36

86.19

2.2

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

815

3989

2.21

85.79

2.1

2.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

799

3880

2.23

85.76

1.9

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

170

322

5.41

85.18

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

116

148

7.98

85.06

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

925

4790

2.11

84.19

2.2

2.5

g/l

66.1

66.0

0.17

856

4288

(3026250) Tacrolimus [Mass/volume] in Blood

113

142

8.10

83.92

41.2

32.0

ug/l

8.1

7.3

2.14

102

127

(3022313) Gas panel - Capillary blood

591

2548

2.47

83.35

6.4

4.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

657

2981

2.36

82.66

14.9

9.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

258

701

3.81

82.07

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

352

1169

3.14

81.84

3.6

2.4

210.1

203.8

0.59

335

1116

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1208

6944

1.93

81.75

7.9

5.7

mmol/l

1.1

1.0

0.63

1124

6396

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

168

327

5.26

81.66

1.3

1.2

titre

130.3

132.6

0.02

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

168

327

5.26

81.66

1.3

1.2

titre

112.7

130.0

0.20

(3028271) Lactate [Moles/volume] in Capillary blood

290

857

3.51

81.41

2.4

1.9

mmol/l

1.6

1.7

0.57

284

834

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

253

5.89

80.44

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

253

5.89

80.44

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

253

5.89

80.44

1.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

154

281

5.60

80.35

2.2

2.1

e6/l

468.7

521.2

0.46

127

232

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

127

193

6.71

79.68

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

127

193

6.71

79.68

1.7

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

127

194

6.67

79.29

1.7

1.9

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2262

15799

1.71

79.24

3.5

2.2

u/l

155.1

227.8

4.47

2135

14707

(21494814) CD8 cells/100 lymphocytes in Specimen

119

170

7.13

79.06

2.1

2.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

347

1168

3.10

78.80

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

347

1168

3.10

78.80

1.5

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1855

12293

1.75

78.42

6.4

4.1

84.4

85.0

0.38

1821

12001

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

144

253

5.81

78.21

1.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

165

332

5.09

77.23

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

296

918

3.34

76.99

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

177

381

4.76

76.51

1.2

96.5

94.3

0.44

172

356

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

209

513

4.19

76.49

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1947

13157

1.72

76.27

4.9

2.8

umol/l

2228.0

5505.0

4.65

1716

11169

(3036489) Thrombin time

424

1625

2.74

75.92

3.3

2.0

21.7

21.8

0.02

387

1464

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1614

10380

1.77

75.17

5.3

4.0

ng/l

428.5

486.0

0.22

1432

8812

(3035350) Ketones [Presence] in Urine by Test strip

3000

22791

1.65

74.63

4.9

3.9

estimate

0.0

0.50

826

4215

(3002032) Base excess in Venous blood by calculation

951

5187

2.00

74.32

4.9

3.7

mmol/l

2.2

1.9

2.00

790

4161

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

703

3442

2.19

73.26

2.0

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

948

5199

1.98

72.81

4.9

3.7

kpa

5.9

5.8

1.09

910

5034

(4015189)

102

135

7.67

72.49

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

2985

22784

1.64

71.76

6.7

5.2

estimate

0.0

0.50

835

4249

(3027945) Reticulocytes/100 erythrocytes in Blood

1144

6709

1.88

71.76

3.5

2.4

1.9

1.8

5.52

1013

5883

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

142

267

5.43

71.71

2.3

2.1

e9/l

0.2

0.11

125

232

(3012544) pH of Venous blood

968

5384

1.96

71.23

4.8

3.7

7.4

—

(4268621)

164

352

4.77

71.13

2.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2368

17096

1.65

70.79

4.3

3.4

mmol/l

2.3

3.10

2125

14605

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

884

4775

2.00

70.73

2.3

2.2

g/l

0.2

1.67

826

4413

(3031040) Bacteria [#/volume] in Urine by Automated count

3917

32081

1.68

70.68

6.5

4.9

e6/l

755.9

1864.1

1.51

553

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

171

383

4.57

70.40

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

3011

23101

1.63

70.33

5.0

4.0

estimate

0.0

1.60

811

4130

(3017569) Oxygen content in Arterial blood

143

279

5.23

69.32

2.2

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

9.24

68.67

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

653

3183

2.18

68.59

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

802

4306

2.00

64.88

5.0

4.0

mmol/l

1.2

2.54

731

3749

(3014007) Fractional oxyhemoglobin in Arterial blood

684

3473

2.10

64.46

14.2

8.5

92.3

93.9

9.48

678

3458

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

127

247

5.23

61.79

2.1

1.5

u/l

6.0

6.7

0.37

112

209

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1304

8282

1.74

61.52

4.2

3.2

e6/l

1.6

1.9

0.97

737

4700

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

547

2593

2.22

61.29

4.9

3.9

mmol/l

24.4

24.1

1.43

492

2318

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1307

8315

1.74

61.25

2.8

2.0

30.0

30.2

0.49

1277

8051

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

172

436

4.03

60.26

1.1

iu/ml

1.8

2.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

667

3460

2.05

59.07

14.5

8.5

0.6

0.7

0.84

659

3432

(3034426) Prothrombin time (PT)

116

7.42

58.83

1.1

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2639

20154

1.57

58.81

5.3

4.1

ng/l

104.3

80.0

0.14

2115

15376

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

118

225

5.33

58.69

1.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

665

3475

2.03

57.65

14.5

8.4

1.4

1.3

1.77

657

3452

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2485

18779

1.57

57.62

3.4

2.9

ug/l

202.2

156.2

7.33

2280

17016

(40761536) Microorganisms panel - Urine sediment

733

3970

1.97

57.39

5.3

4.2

—

(3002385) Erythrocyte distribution width [Ratio]

4226

36058

1.63

57.33

38.1

20.4

14.3

13.9

61.84

4189

35177

(3023520) Reticulocytes [#/volume] in Blood

881

5096

1.86

56.42

3.4

2.5

e9/l

73.2

67.8

3.24

617

3890

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

454

2068

2.30

55.83

3.9

2.9

u/ml

0.3

0.75

276

1176

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

9.79

55.39

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

120

246

4.96

54.98

2.5

2.6

39.1

36.4

0.57

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1886

13522

1.58

54.10

2.6

2.3

mg/l

3.2

3.1

2.46

1661

11414

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.94

53.59

1.1

—

(3019977) pH of Arterial blood

136

316

4.38

53.47

2.6

2.3

7.4

0.18

103

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

139

6.41

53.22

2.2

2.0

30.4

30.0

0.07

127

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.64

52.57

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

139

6.34

52.04

2.2

2.0

9.6

12.3

0.77

123

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

188

565

3.41

51.32

1.1

g/l

1.6

0.01

166

504

(3015736) pH of Urine

2354

17902

1.53

51.08

4.2

3.7

—

5.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1329

8867

1.65

50.73

3.9

3.0

e6/l

1.0

1.2

1.25

765

5246

(4035726)

758

4332

1.86

50.01

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

126

295

4.34

49.07

2.4

2.0

e6/l

643.2

596.9

0.26

128

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

905

5489

1.77

48.98

4.9

3.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

474

2330

2.13

48.10

6.0

4.9

1.8

1.6

3.82

447

2182

(3020891) Body temperature

457

2218

2.15

47.92

5.7

4.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

246

911

2.78

46.80

1.4

1.3

—

(3047181) Lactate [Moles/volume] in Blood

373

1695

2.28

45.95

8.4

5.8

mmol/l

1.4

1.3

0.66

343

1498

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

10.28

45.74

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2825

22649

1.48

45.64

3.0

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

733

4260

1.82

45.56

3.8

3.2

kpa

4.5

0.08

700

4109

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

881

5416

1.74

45.18

3.1

2.7

umol/l

10.5

9.3

0.63

769

4729

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

445

2188

2.12

45.05

7.3

4.3

mmol/l

25.0

24.8

1.16

423

1990

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

236

894

2.71

42.97

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

242

932

2.67

42.65

4.0

3.7

1.5

0.06

211

696

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

519

2758

1.97

42.36

1.9

1.7

g/l

1.6

0.55

435

2356

(3024891) Influenza virus A+B Ag [Presence] in Specimen

265

1072

2.54

42.26

1.3

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

397

1914

2.15

42.23

3.5

2.2

ug/l

387.8

636.3

1.14

376

1814

(3037756) Immunofixation for Serum or Plasma

297

1272

2.41

41.88

1.5

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

199

4.78

41.51

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

394

1908

2.14

41.42

2.5

3.2

mg/l

62.1

90.8

0.47

285

1579

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

393

1904

2.14

41.27

2.5

3.2

mg/l

43.4

55.1

0.78

283

1576

(3041096) Erythrocytes [Presence] in Urine by Automated

1625

11831

1.52

41.05

5.0

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4969

45276

1.67

40.56

34.8

16.8

mg/l

25.1

26.8

3.75

4654

36887

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

383

1861

2.13

39.89

2.5

3.2

ratio

4.1

3.6

0.11

142

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

184

4.84

39.45

1.2

ratio

1.1

0.09

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

252

1033

2.50

39.07

1.9

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

13.93

39.05

1.1

1.0

—

(3021788) Differential panel - Synovial fluid

230

909

2.59

38.48

1.7

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

337

1585

2.20

38.10

4.2

3.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

442

2303

1.99

38.07

6.4

5.0

0.9

0.27

414

2161

(3029937) Albumin [Presence] in Urine by Test strip

1695

12610

1.49

37.96

5.4

4.4

estimate

0.0

0.88

775

4017

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

350

1680

2.15

37.59

2.4

2.2

g/l

0.1

0.10

324

1521

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

150

477

3.20

37.42

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2008

15481

1.45

37.28

3.0

2.6

u/l

61.6

58.8

0.42

1873

14226

(3039000) Anion gap in Blood

279

1227

2.34

37.03

8.4

6.6

mmol/l

11.7

11.2

1.73

256

1096

(3018572) Chloride [Moles/volume] in Blood

279

1227

2.34

37.03

8.4

6.7

mmol/l

103.8

105.2

4.92

256

1096

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

141

5.30

36.90

1.1

u/ml

27.9

6.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

892

5791

1.64

36.61

2.2

1.8

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

329

1558

2.18

36.55

2.4

2.2

g/l

0.0

0.79

303

1404

(3044889) 12 lead EKG panel

3818

33148

1.44

36.43

5.8

4.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

410

2114

2.01

36.34

2.4

2.3

g/l

3.3

3.1

3.94

331

1638

(3018405) Lactate [Moles/volume] in Arterial blood

395

2012

2.03

36.21

4.7

3.8

mmol/l

1.4

0.28

389

1978

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

324

1531

2.18

36.19

2.5

2.3

g/l

0.0

0.00

303

1398

(3026008) Bacteria identified in Urine by Culture

2023

15686

1.44

36.15

3.8

3.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2281

1.97

36.10

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2283

1.97

36.00

2.3

g/l

7.8

7.4

4.12

335

1662

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

411

2128

2.00

36.00

2.4

2.3

g/l

10.6

10.2

0.69

350

1774

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

2277

1.97

35.95

2.3

g/l

3.9

3.8

0.28

327

1600

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

376

1921

2.02

34.16

2.4

g/l

0.7

1.0

0.96

334

1624

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

235

1004

2.40

33.30

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

349

1759

2.05

32.90

2.4

2.2

g/l

35.9

37.4

4.38

316

1475

(3029075) Extractable nuclear Ab panel - Serum

5.99

32.41

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

141

472

3.04

32.28

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

296

1429

2.13

31.28

2.4

3.3

—

(40768797) Stomach Pathology biopsy report

957

6564

1.55

30.63

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1333

9799

1.47

30.53

3.0

3.1

mmol/l

2.5

8.60

1183

8531

(3007566) Smooth muscle Ab [Titer] in Serum

244

1117

2.24

29.46

1.3

1.2

titre

107.1

93.9

0.22

(3034770) Mitochondria Ab [Titer] in Serum

243

1126

2.21

28.48

1.2

titre

977.5

993.5

0.02

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.55

28.44

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1461

11050

1.43

28.42

4.3

3.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3204

27573

1.36

28.25

4.5

3.1

u/l

65.9

55.1

4.91

2977

25057

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2151

17446

1.37

27.47

5.3

4.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

320

1670

1.97

27.32

1.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

282

1415

2.04

26.88

1.6

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

546

3375

1.68

26.65

4.7

3.3

g/l

125.9

127.6

1.06

527

3289

(3000060) B lymphocytes [#/volume] in Blood

5.53

26.26

2.3

1.9

e6/l

958.8

1712.6

0.24

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

162

651

2.53

26.25

1.1

1.3

miu/ml

195.3

207.1

0.12

238

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1144

8388

1.45

25.98

1.3

1.2

u/ml

1.1

1.7

3.18

290

2071

(3043409) Potassium [Moles/volume] in Arterial blood

317

1695

1.92

25.19

5.4

4.1

mmol/l

4.0

3.9

2.28

289

1576

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

148

4.29

24.56

1.3

2.1

197.5

167.7

1.18

139

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

114

401

2.88

23.98

1.8

mg/l

4.5

4.6

0.05

106

382

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

248

1246

2.03

23.57

3.5

3.0

mg/l

1.8

1.7

0.74

229

1109

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.09

23.49

1.1

89.8

82.4

0.74

(3036782) Glucose [Moles/volume] in Pleural fluid

148

601

2.50

23.49

1.5

1.4

mmol/l

6.6

6.4

0.25

134

554

(3025941) Bacteria identified in Stool by Culture

397

2326

1.76

23.47

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

664

4442

1.56

23.33

2.7

2.4

u/l

36.2

48.4

0.57

603

3774

(3051651) Icteric interference index of Serum or Plasma

308

3.12

23.07

5.5

3.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

156

656

2.42

22.97

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

147

602

2.48

22.93

4.9

4.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

107

4.80

22.87

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

148

610

2.46

22.77

1.7

1.5

59.1

62.5

0.47

401

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

123

466

2.67

22.51

1.9

1.4

39.1

25.9

3.26

296

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

133

4.32

22.44

2.4

2.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

32.37

22.37

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

450

2766

1.68

22.34

4.6

3.5

mmol/l

25.6

25.1

2.02

425

2681

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

261

1371

1.95

21.87

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

235

1192

2.01

21.77

1.9

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

100

4.83

21.72

1.1

1.3

90.7

81.1

0.84

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

118

449

2.66

21.43

1.7

1.5

u/l

14.2

13.3

0.68

113

429

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

603

4047

1.55

20.78

1.7

1.6

2.06

507

3417

(3019309) Folate [Moles/volume] in Red Blood Cells

1419

11161

1.36

20.73

1.9

1.8

nmol/l

1186.9

1163.9

0.37

1074

8331

(3000475) Leukocytes [#/volume] in Synovial fluid

240

1248

1.96

20.72

1.8

1.6

e6/l

13794.1

14691.1

0.09

182

902

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

390

2362

1.70

20.44

2.7

1.9

—

(3045142) Bone marrow Pathology biopsy report

142

604

2.38

20.43

1.5

1.3

—

(3045716) Anion gap in Serum or Plasma

255

3.17

20.04

2.1

2.2

mmol/l

8.5

9.4

1.35

202

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

120

478

2.54

19.89

1.3

u/l

14.7

12.7

0.43

108

437

(3034891) Synovial lining cells/100 cells in Synovial fluid

226

3.30

19.88

1.7

1.4

3.8

4.1

0.07

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

4.55

19.80

1.6

1.4

ug/l

8.1

9.5

1.31

104

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.97

19.67

1.5

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

217

1112

1.99

19.55

2.8

2.5

umol/l

33.3

34.7

0.32

191

928

(40768804) Tissue Pathology biopsy report

2217

18720

1.30

19.37

2.4

2.2

—

(3004451) EKG impression Narrative

289

2.97

19.08

1.4

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1587

12825

1.33

19.04

1.8

1.6

nmol/l

18.9

20.1

2.42

1416

10853

(3042111) Morphology [Interpretation] in Bone marrow Narrative

197

987

2.03

18.92

1.8

1.5

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

141

625

2.29

18.49

1.4

1.3

u/l

484.1

382.7

0.58

130

589

(3017732) Neutrophils [#/volume] in Blood

467

3037

1.58

18.42

3.3

e9/l

4.6

4.2

1.81

372

2178

(3012441) Differential panel - Pleural fluid

150

685

2.22

18.32

1.6

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.17

18.12

1.2

1.4

—

(3044941) Cell count panel - Synovial fluid

168

807

2.11

18.07

1.8

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

402

2534

1.63

18.04

3.9

2.7

0.7

0.6

0.83

394

2424

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

161

762

2.14

17.99

1.2

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

181

900

2.04

17.76

1.5

g/l

32.5

31.4

0.58

156

805

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.10

17.38

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

262

2.96

17.30

4.0

3.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

170

836

2.06

17.20

2.9

3.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

137

619

2.24

17.19

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

308

2.79

17.04

1.7

1.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

154

734

2.13

16.93

8.1

6.2

mg/l

12.0

12.1

0.08

143

673

(3000093) Morphology [Interpretation] in Blood Narrative

120

522

2.33

16.48

1.3

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

637

4529

1.46

16.44

2.3

2.1

ug/g

194.6

164.7

0.95

522

3512

(3026389) Candida sp identified in Specimen by Organism specific culture

129

582

2.24

16.27

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.46

16.09

1.7

1.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.61

15.68

1.1

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3669

33456

1.26

15.57

4.1

3.8

pmol/l

15.0

0.28

3312

29779

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

112

487

2.33

15.42

1.1

1.2

u/l

56.8

63.8

0.60

323

(3024928) Oxygen saturation in Venous blood

205

1122

1.86

15.23

3.9

3.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

570

4026

1.46

15.18

4.3

3.8

ng/l

104.9

96.9

0.81

495

3395

(3019832) Treponema pallidum Ab [Presence] in Serum

274

1637

1.71

15.12

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

250

1458

1.75

15.04

1.4

1.5

ug/g

290.2

264.7

0.43

156

875

(3045788) Cell count panel - Pleural fluid

129

603

2.17

14.95

1.6

1.5

—

(40768806) Pleura Pathology biopsy report

142

690

2.08

14.89

1.5

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

326

2.60

14.79

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

105

455

2.33

14.60

1.3

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

192

3.09

14.38

4.2

3.9

60.5

54.5

1.24

185

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

341

2186

1.59

14.28

2.3

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

120

556

2.18

14.23

5.1

3.5

—

(40768446) Kidney Pathology biopsy report

158

3.31

14.18

1.4

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

551

3937

1.44

13.78

3.8

2.8

ml/min/173m2

56.7

61.0

2.06

264

1669

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.24

13.59

1.7

1.8

mg/l

6.2

9.0

2.03

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2538

22427

1.23

13.39

5.1

4.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.46

13.28

1.3

1.2

ng/l

120.2

1242.3

0.50

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

146

751

1.97

13.13

1.6

1.9

ug/l

23.1

24.1

0.08

141

733

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.69

12.73

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.69

12.73

1.2

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

225

1338

1.71

12.67

3.0

3.1

nmol/l

0.9

0.8

0.35

175

1004

(3050794) Legionella sp Ab [Presence] in Serum

5.63

12.40

1.1

—

(40761511) CBC panel - Blood by Automated count

4854

46218

1.31

12.34

27.3

16.2

—

(3044927) Protein electrophoresis panel - Urine

123

612

2.03

12.18

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

271

2.56

11.94

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

271

2.56

11.94

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.41

11.89

1.0

1.2

93.4

75.8

—

(3009508) Creatinine [Moles/volume] in Urine

1873

16174

1.23

11.87

3.6

3.2

mmol/l

7.1

7.4

1.89

1557

13314

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.37

11.81

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

9.35

11.65

1.4

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1359

11347

1.26

11.63

1.8

1.7

pmol/l

39763897.9

26919321.6

0.27

1099

9198

(3010726) Horse dander IgE Ab [Units/volume] in Serum

324

2.40

11.52

1.1

u/ml

2.6

1.5

0.38

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

1.3

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

3.4

2.7

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

2.8

0.6

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

0.8

0.9

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

5.2

2.2

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

2.2

3.3

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

6.2

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.35

11.48

1.6

1.2

mg/l

1.5

3.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2444

21739

1.21

11.45

2.2

2.1

pmol/l

91.3

93.1

1.13

1332

11411

(3040151) Glucose [Moles/volume] in Capillary blood

128

661

1.96

11.44

14.8

18.4

mmol/l

7.5

0.09

113

545

(3023199) Leukocytes [#/volume] in Pleural fluid

146

789

1.87

11.39

1.6

1.5

e6/l

4924.1

1854.6

0.62

572

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

332

2.37

11.39

1.4

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

254

2.58

11.38

1.0

1.1

u/ml

1.6

3.3

0.84

102

(3019550) Sodium [Moles/volume] in Serum or Plasma

4971

47593

1.31

11.34

35.7

20.0

mmol/l

139.0

139.6

46.61

4910

46309

(3035880) pH of Pleural fluid

365

2.29

11.25

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

2.49

11.10

1.0

1.1

u/ml

3.5

2.6

0.24

113

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

193

1143

1.71

11.08

1.3

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1828

15833

1.23

11.07

3.6

3.2

mg/l

685.1

313.1

2.06

1230

10150

(3028308) Erythrocytes [#/volume] in Pleural fluid

134

712

1.90

11.02

1.5

e6/l

130291.5

61688.3

0.93

419

(3009542) Hematocrit [Volume Fraction] of Blood

4180

39254

1.23

11.02

34.1

18.2

38.8

0.20

2658

24885

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

7.91

11.00

1.6

1.3

mg/l

0.2

2.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.26

11.00

1.1

1.2

77.0

82.1

—

(3000012) Reticulocyte production index

313

2.38

10.97

2.0

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

440

2.16

10.97

1.1

u/ml

1.5

2.4

0.41

180

(3017354) Segmented neutrophils/100 leukocytes in Blood

114

576

2.00

10.86

4.6

3.5

54.5

59.3

1.37

350

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

675

5189

1.34

10.80

2.6

2.4

ug/l

10.8

6.8

4.06

590

4463

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

149

3.04

10.74

1.1

u/ml

14.3

2.3

1.08

(3023103) Potassium [Moles/volume] in Serum or Plasma

4973

47684

1.30

10.70

36.0

20.2

mmol/l

4.0

3.29

4905

46333

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

305

2.38

10.65

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

283

2.42

10.46

1.1

1.2

u/l

95.8

88.6

0.27

242

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

272

2.44

10.38

1.1

1.2

u/l

44.2

23.1

1.47

228

(3003888) Timothy IgE Ab [Units/volume] in Serum

385

2.20

10.35

1.1

u/ml

3.9

3.8

0.03

185

(44806071)

5.14

10.30

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

153

2.96

10.27

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

123

655

1.90

10.08

1.1

—

(40768443) Skin Pathology biopsy report

322

2204

1.49

10.06

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

217

2.60

10.02

6.0

4.5

mg/l

61.7

69.0

0.45

149

(3044640) Blood type and Crossmatch panel - Blood

1802

15734

1.21

9.79

3.2

2.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

641

4973

1.32

9.60

1.4

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.02

9.54

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

135

755

1.81

9.51

1.1

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1901

16724

1.20

9.46

4.5

4.0

mg/mmol

12.8

9.6

1.57

1238

10625

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.27

9.11

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

222

2.49

9.09

1.0

u/ml

0.2

0.3

0.18

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

184

2.62

8.82

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.66

8.81

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.66

8.81

1.5

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.66

8.81

1.5

1.1

—

(3017704) Immunofixation for Urine

333

2.18

8.74

1.3

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

174

2.66

8.68

5.7

6.9

mmol/l

24.5

0.01

158

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4319

41013

1.21

8.66

5.1

4.7

mu/l

2.1

0.08

3939

36709

(3022145) Colonoscopy Study observation

659

5206

1.30

8.63

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4957

47762

1.26

8.54

20.7

11.1

u/l

24.8

25.6

2.48

4891

45663

(36660697) Celiac disease serology panel - Serum

411

3041

1.38

8.40

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

469

1.96

8.30

1.2

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

375

2.07

8.21

1.1

u/ml

0.5

1.4

1.35

162

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

297

2.20

8.16

1.4

1.6

u/l

8.9

6.4

0.58

138

(3022217) INR in Platelet poor plasma by Coagulation assay

962

8011

1.24

8.11

29.8

29.4

inr

1.5

0.04

101

1121

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.75

8.10

1.3

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

135

2.83

8.09

1.3

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

236

2.34

8.00

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.87

7.98

1.8

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

237

2.33

7.93

1.1

1.0

—

(3036603) Volume of Urine

323

2.12

7.77

1.4

1.7

1834.5

1805.3

0.05

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

512

6530

0.76

7.70

9.8

8.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

714

5780

1.27

7.69

3.2

4.0

ug/l

14.3

23.8

1.17

589

4785

(3006922) Hepatitis E virus Ab [Presence] in Serum

249

2.26

7.53

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.09

7.52

1.6

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

550

1.83

7.52

2.6

3.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

206

2.39

7.49

1.3

mmol/l

3.7

3.5

0.14

185

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

386

1.98

7.28

1.6

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4433

42415

1.19

7.18

29.3

16.0

ml/min/173m2

73.5

74.3

1.65

4002

35179

(3003181) Sodium [Moles/volume] in Urine

152

952

1.61

7.18

1.4

1.3

mmol/l

66.3

62.5

0.56

137

764

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.44

7.10

1.4

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

191

1267

1.52

7.03

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

391

1.96

7.03

1.6

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

192

1276

1.52

7.01

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4441

42527

1.19

6.99

6.9

6.5

mmol/mol

41.5

40.8

3.67

4111

38663

(3001893) Eosinophils/100 leukocytes in Pleural fluid

213

2.31

6.97

1.4

2.5

0.80

180

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1375

12037

1.19

6.81

3.1

2.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

378

2861

1.34

6.72

2.6

2.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

127

2.69

6.65

6.4

7.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

105

2.87

6.61

1.3

1.5

4.0

6.1

0.61

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

122

2.71

6.58

5.2

2.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

284

2.09

6.57

1.7

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

284

2.09

6.57

1.7

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

1256

1.51

6.52

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

310

2293

1.37

6.41

2.6

3.3

pmol/l

4.2

4.4

1.65

266

1995

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.58

6.30

1.3

1.0

iu/ml

6.2

6.9

0.10

(44813793)

232

2.17

6.14

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

121

2.65

6.14

1.2

mmol/l

2.0

1.6

1.02

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

354

1.93

6.13

1.1

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

201

2.25

6.06

1.1

iu/ml

7.6

13.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

261

2.08

5.99

1.4

60.3

68.9

0.78

213

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

2.35

5.96

3.3

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

171

2.35

5.96

3.4

2.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.85

5.92

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

284

2.02

5.84

2.4

1.8

—

(3024263) Appearance of Synovial fluid

295

1.98

5.62

2.0

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.19

5.58

1.5

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

161

1086

1.50

5.56

1.6

1.4

—

(3037121) Protein [Mass/volume] in Urine

248

1813

1.38

5.55

2.9

3.1

g/l

0.4

0.3

0.74

125

764

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

148

984

1.52

5.48

1.1

u/ml

19.8

8.6

0.65

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

513

6280

0.80

5.47

4.7

4.8

32.4

33.1

0.71

376

4087

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

139

913

1.54

5.45

1.2

1.3

u/l

45.8

40.3

0.13

122

789

(3025018) Bordetella pertussis Ab [Titer] in Serum

185

2.22

5.43

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

482

1.73

5.33

1.1

—

(3013512) EKG study

1686

15248

1.15

5.28

5.2

4.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

242

2.03

5.18

1.2

1.1

u/l

33.4

35.7

0.08

174

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

242

2.03

5.18

1.2

1.1

u/l

94.4

92.7

0.04

179

(3020491) Glucose [Moles/volume] in Blood

354

1.85

5.17

2.1

2.2

mmol/l

7.5

6.9

1.01

232

(21494434) Karyotype in Bone marrow

494

1.71

5.17

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

4.01

5.16

1.1

g/l

0.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

121

2.49

5.11

1.7

1.5

ug/l

0.3

0.4

0.61

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

313

1.89

5.10

1.0

mg/l

293.8

285.3

0.42

275

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.45

5.03

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

137

2012

0.67

5.00

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

103

647

1.60

4.94

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

103

653

1.59

4.76

1.6

1.4

—

(3001729) Color of Synovial fluid

3.28

4.74

2.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

102

647

1.59

4.71

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

102

647

1.59

4.71

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

102

649

1.58

4.66

1.6

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.64

4.64

1.3

18.8

21.2

0.11

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.69

4.64

1.3

ml/s/173m2

0.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

165

2307

0.71

4.62

1.9

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

128

2.35

4.56

1.3

1.2

—

(3016750) Collection duration of Urine

311

1.84

4.56

2.2

2.0

min

476.0

492.9

0.50

216

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.98

4.55

1.3

nmol/l

12.0

146303.6

0.49

(3045424) Erythrocytes [Presence] in Urine

122

813

1.51

4.54

1.8

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

662

1.57

4.52

1.6

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

111

2.44

4.45

6.2

7.8

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.77

4.44

1.5

1.4

71.1

74.5

0.19

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

169

2.14

4.39

1.4

23.7

21.6

0.15

138

(3002523) Influenza virus A Ag [Presence] in Specimen

396

1.73

4.39

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.01

4.39

2.1

1.4

umol/l

41.7

43.6

0.13

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.01

4.39

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

237

1.95

4.38

1.5

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.51

4.35

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

504

1.64

4.34

1.7

1.3

e6/l

105988.9

110412.3

0.02

353

(3004716) Salmonella sp identified in Stool by Organism specific culture

223

1674

1.35

4.30

1.4

1.3

—

(3012565) Volume of 24 hour Urine

246

1.92

4.28

1.7

2.4

1994.8

1877.5

0.42

205

(3011648) Oxygen content in Venous blood

400

1.71

4.25

5.8

2.3

10.8

10.9

0.08

400

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.04

4.23

1.1

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.91

4.16

1.3

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.91

4.16

1.6

1.2

ug/l

102.4

119.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

6.93

4.16

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

235

1.92

4.14

1.5

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

160

2.13

4.14

5.6

1.8

umol/l

152.9

130.5

0.18

(3003740) Influenza virus B Ag [Presence] in Specimen

397

1.70

4.09

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

617

1.55

4.02

1.5

2.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1338

12123

1.13

3.91

1.8

1.6

mmol/l

1.4

1.3

3.69

1097

10042

(3016038) Potassium [Moles/volume] in Urine

358

1.71

3.88

1.3

1.2

mmol/l

32.6

34.5

0.32

301

(3024731) MCV [Entitic volume]

5033

49237

1.17

3.85

45.4

24.6

92.5

91.6

28.63

4987

48303

(3035941) MCH [Entitic mass]

5033

49237

1.17

3.85

45.3

24.6

30.5

30.4

0.64

4989

48303

(3007461) Platelets [#/volume] in Blood

5032

49228

1.17

3.84

45.6

24.7

e9/l

245.2

240.7

4.64

4950

47716

(3026361) Erythrocytes [#/volume] in Blood

5033

49240

1.17

3.83

45.5

24.7

e12/l

4.4

15.32

4934

47545

(3035320) C reactive protein [Mass/volume] in Body fluid

337

1.73

3.82

3.0

2.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.07

3.80

1.5

1.7

—

(3010813) Leukocytes [#/volume] in Blood

5033

49250

1.16

3.77

45.6

24.7

e9/l

7.8

6.9

67.49

4937

47543

(3000963) Hemoglobin [Mass/volume] in Blood

5033

49251

1.16

3.77

45.9

24.9

g/l

131.4

133.8

23.60

4988

48329

(3008295) Osmolality of Serum or Plasma

508

1.58

3.76

1.4

1.3

mosm/kgh2o

272.1

277.8

1.32

379

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

417

1.64

3.69

1.9

u/l

5101.3

2495.0

0.27

157

(3020393) Adenovirus Ag [Presence] in Stool

3.05

3.52

1.2

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

102

1470

0.69

3.48

1.6

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

214

1.88

3.48

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.89

3.46

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.98

3.41

3.6

2.6

mg/l

0.7

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

3.36

7.3

8.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

203

1.88

3.33

1.2

1.3

ug/l

126.8

545.2

1.04

105

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.58

3.19

1.5

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.58

3.19

1.4

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1269

11593

1.12

3.18

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

1.87

3.05

2.9

2.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

498

4279

1.18

3.03

1.7

1.6

—

(3047189) Immunofixation for 24 hour Urine

292

1.68

3.02

1.7

1.6

—

(40768441) Liver Pathology biopsy report

300

1.67

3.01

1.5

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.28

2.93

1.4

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

101

2.18

2.92

1.2

mg/l

0.8

98.3

0.80

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.71

2.91

1.6

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

649

1.44

2.89

1.6

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.70

2.88

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1147

0.68

2.87

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

420

3576

1.19

2.86

2.6

2.1

nmol/l

12.3

12.1

0.28

360

3080

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.17

2.76

1.3

1.2

mmol/l

0.5

1.9

1.28

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.01

2.69

1.3

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

126

1.99

2.64

1.0

1.1

miu/ml

1727.0

1651.6

0.09

126

(3004775) Volume in Urine collected for unspecified duration

449

1.50

2.59

2.3

2.2

589.9

653.5

0.68

274

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.19

2.56

1.3

1.2

u/l

383.8

429.1

0.04

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

426

1.51

2.55

1.2

1.4

—

(3016135) IgD [Mass/volume] in Serum

7.15

2.55

1.4

1.3

mg/l

242.2

121.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.47

2.48

1.1

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.81

2.46

1.6

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

248

1.66

2.45

1.6

1.3

nmol/l

1.2

0.11

186

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.46

2.44

4.1

4.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

187

1497

1.26

2.39

1.6

—

(3041184) Isoniazid [Presence] in Urine

6.25

2.37

2.6

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.64

2.36

2.1

5.6

—

(3030313) Adrenal Ab [Titer] in Serum

4.12

2.36

1.3

1.0

—

(3019150) Specific gravity of Urine by Refractometry

1113

10264

1.10

2.31

5.4

4.4

kg/l

1.0

0.08

202

1594

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

126

1.91

2.30

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.23

2.27

1.3

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.89

2.25

1.3

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

224

1.66

2.23

1.1

1.6

umol/l

5.7

11.0

1.09

150

(3036670) Protein [Mass/volume] in Synovial fluid

179

1.74

2.22

1.2

g/l

32.3

40.5

2.01

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.56

2.21

2.4

4.4

—

(3000330) Specific gravity of Urine by Test strip

233

2799

0.83

2.19

4.9

3.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

260

2177

1.20

2.19

1.2

iu/ml

118.8

140.5

0.41

761

(3009214) Lutropin [Units/volume] in Serum or Plasma

103

773

1.34

2.17

1.4

u/l

10.1

10.5

0.11

625

(40758292) HTLV I+II Ab panel - Serum

2.30

2.14

1.2

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

2.05

2.11

2.4

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.56

2.09

1.3

1.2

mmol/l

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

2.06

0.0

5.5

—

8.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.40

2.02

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

327

1.50

2.00

1.4

1.3

promille

1.1

1.2

0.08

248

(3038177) Helicobacter pylori Ab [Presence] in Serum

560

1.38

2.00

1.2

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

322

2775

1.17

1.98

2.4

au/ml

53.7

26.0

—

102

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.15

1.98

1.2

u/l

19.4

—

(3044290) Cell count panel - Cerebral spinal fluid

110

848

1.30

1.95

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

1.81

1.93

1.9

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

104

797

1.31

1.93

1.4

iu/l

33.5

30.4

0.37

680

(3048879) Bone marrow aspiration report

172

1.69

1.92

2.2

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

292

2504

1.17

1.92

1.3

au/ml

44.8

58.1

—

102

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.57

1.92

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.57

1.92

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

203

1.63

1.91

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

818

0.71

1.91

1.7

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

121

1.82

1.88

2.0

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

151

1.73

1.86

1.0

1.2

—

(3019174) dRVVT (LA screen)

2.86

1.86

1.4

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

285

1.51

1.84

1.7

u/field

1.5

2.9

0.76

194

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

442

1.41

1.83

1.5

1.6

u/ml

14.2

26.0

—

102

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

198

1.62

1.83

1.1

1.2

60.7

62.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

700

1.32

1.82

2.8

2.1

mg/l

24.2

25.9

0.12

166

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.80

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1638

17256

0.93

1.77

4.3

4.7

21.8

22.1

0.34

742

9128

(3035637) Corticotropin [Mass/volume] in Plasma

566

1.35

1.74

1.6

1.5

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.34

1.74

2.8

1.9

mmol/l

4.3

4.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

201

1.60

1.73

1.3

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

291

1.48

1.69

2.0

1.7

—

(4027681)

187

1.61

1.68

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

393

0.61

1.66

2.0

1.6

—

(3014891) Appearance of Pleural fluid

1.89

1.65

2.0

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.59

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

125

1539

0.81

1.59

5.8

4.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.69

1.58

1.0

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

247

1.50

1.57

1.5

1.6

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

129

1.71

1.56

1.3

g/l

0.4

0.3

1.17

101

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.85

1.55

1.1

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

107

1.78

1.54

1.4

1.1

pmol/l

302.4

270.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

314

1.44

1.54

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.97

1.53

12.4

13.3

mmol/l

5.7

5.3

0.43

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

1.51

0.0

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.86

1.50

5.4

7.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

228

1964

1.17

1.48

3.1

3.3

u/ml

12013.2

1525.9

0.42

186

1678

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

676

0.72

1.48

1.6

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

178

1.58

1.48

1.3

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.50

1.45

1.4

1.5

—

(3020650) Glucose [Presence] in Urine

102

1.77

1.44

1.5

1.6

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

755

1.26

1.41

1.3

1.7

mu/l

310.7

303.4

0.09

695

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

375

0.64

1.40

1.0

ng/l

313.9

328.3

0.08

244

(3008898) HLA-B27 [Presence]

122

999

1.23

1.40

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.18

1.39

1.2

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.18

1.39

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.38

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

127

1.66

1.36

1.0

1.2

22.7

29.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

1.2

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

1.70

1.35

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

144

1.60

1.31

2.1

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

559

1.29

1.31

1.6

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

1.31

0.0

1.2

—

11.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

377

0.66

1.26

1.0

ng/l

35.4

45.0

0.42

242

(3002256) Pathology report gross observation

689

6402

1.09

1.26

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

375

0.67

1.24

1.0

ng/l

793.7

686.3

0.85

236

(40757494) Bilirubin.total [Moles/volume] in Blood

296

1.39

1.22

2.5

2.7

umol/l

23.4

34.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

426

1.32

1.20

1.0

1.1

u/ml

17.3

2.5

0.79

141

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

168

0.54

1.18

1.7

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

198

1.47

1.16

3.0

2.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.16

0.0

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4483

44209

1.06

1.15

5.3

5.1

mmol/l

6.1

0.46

4029

39464

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.05

1.15

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.50

1.15

1.6

9.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

136

1155

1.18

1.12

3.0

3.2

u/ml

86.7

768.2

1.96

126

1052

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

730

0.78

1.10

2.0

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

176

1.48

1.10

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

206

0.58

1.07

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

206

0.58

1.07

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.69

1.07

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

205

0.58

1.06

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

205

0.58

1.06

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.12

1.05

1.1

—

(40765096) Chromosome analysis panel by Banding

170

1.47

1.04

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.27

1.03

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

256

1.37

1.00

2.5

2.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

239

1.38

1.00

1.6

1.5

g/l

1.0

0.9

0.32

239

(3013139) Helicobacter pylori Ag [Presence] in Stool

263

2920

0.90

0.99

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

100

1.60

0.96

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

235

0.64

0.95

1.3

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

282

0.67

0.94

1.9

1.8

—

(3025315) Body weight

1.89

0.94

5.3

4.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

615

1.22

0.93

1.5

1.3

nmol/l

12.2

0.7

0.49

586

(3020876) Protein [Mass/time] in 24 hour Urine

498

1.25

0.93

1.9

g/24h

0.6

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

295

1.32

0.92

2.1

ug/min

61.2

199.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

192

1.41

0.92

1.4

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

437

1.26

0.91

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

110

1.55

0.90

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

254

1.34

0.88

1.1

mg/l

279.0

296.8

0.27

217

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

620

1.21

0.88

1.5

1.3

nmol/l

0.2

0.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

584

0.79

0.87

1.6

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

110

942

1.17

0.87

1.1

1.2

mmol/l

3.8

3.9

0.39

101

872

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

216

0.65

0.85

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

241

2181

1.11

0.84

2.4

2.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

222

1.35

0.83

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

267

1.31

0.80

1.2

1.1

mg/l

51.0

44.6

0.31

219

(4034850)

170

1515

1.13

0.79

12.9

11.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.73

0.79

1.7

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.73

0.79

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.79

0.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

1273

13201

0.95

0.78

3.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

175

0.63

0.78

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.59

0.78

1.1

u/ml

1.2

52.9

—

(1002224) Polysomnography panel

143

1263

1.14

0.77

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

197

1775

1.11

0.77

1.5

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

123

1076

1.15

0.77

1.2

1.3

mg/l

740.2

548.2

0.40

112

1010

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.70

0.75

1.7

2.5

u/field

0.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

651

1.19

0.74

3.2

3.8

u/ml

27.6

32.2

0.34

630

(3025130) Human papilloma virus identified in Specimen

280

1.29

0.74

1.9

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.80

0.72

1.0

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

221

1.31

0.69

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

144

1.39

0.67

1.2

—

(3049717) Cytology report of Urine Cyto stain

271

2502

1.09

0.67

2.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

168

0.65

0.67

1.3

1.4

—

(40768800) Prostate Pathology biopsy report

126

1418

0.89

0.67

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.55

0.67

1.8

1.7

—

(3005033) Fetal Nuchal fold Thickness US

167

0.66

0.65

1.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.65

2.1

1.7

—

(4281824)

436

0.80

0.62

1.1

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

534

1.18

0.62

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1183

12218

0.96

0.62

3.0

3.2

ug/l

0.7

0.8

2.83

848

8724

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

182

1.32

0.61

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

416

1.20

0.60

2.2

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

105

1.43

0.60

1.7

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

770

1.15

0.59

3.6

2.4

mmol/l

105.6

105.7

0.07

760

(3041354) Potassium [Moles/volume] in Venous blood

770

1.15

0.59

3.6

2.4

mmol/l

4.1

0.12

760

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

291

1.24

0.58

1.8

1.5

nmol/l

0.2

0.3

2.00

217

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

298

0.77

0.57

1.2

1.4

u/l

24.7

31.0

0.63

243

(3027008) Opiates [Presence] in Urine

540

1.17

0.56

2.0

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

755

1.14

0.56

3.7

2.5

—

(3019225) pH of Specimen

567

5412

1.05

0.56

5.2

4.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4245

42064

1.03

0.54

4.3

4.2

mmol/l

1.3

7.44

3753

37508

(3028300) Cannabinoids [Presence] in Urine

542

1.16

0.54

2.0

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

633

0.85

0.54

3.3

4.4

umol/l

325.2

347.4

0.48

538

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

151

1.33

0.53

1.1

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

240

1.25

0.53

1.0

1.1

—

(3022621) pH of Urine by Test strip

353

3329

1.06

0.53

4.2

3.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.54

0.53

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

470

1.17

0.52

1.8

2.0

u/field

1.7

0.01

167

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

223

2073

1.08

0.51

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

837

1.13

0.51

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

188

1.28

0.51

1.0

1.1

u/l

1.1

0.91

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

242

1.24

0.50

3.7

6.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

565

1.15

0.50

1.2

1.3

pmol/l

282.5

262.8

0.16

422

(3003338) MCHC [Mass/volume]

3660

36206

1.03

0.50

41.1

22.1

g/l

329.3

331.8

50.30

3634

35844

(3016879) Cocaine [Presence] in Urine

501

1.16

0.49

2.1

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

102

916

1.12

0.49

1.2

1.4

e6/l

84.5

973.6

3.73

750

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

548

1.15

0.49

1.5

1.3

nmol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

144

0.69

0.49

1.6

1.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.56

0.49

1.1

—

(3027944) Amphetamines [Presence] in Urine

531

1.15

0.47

1.9

1.8

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

336

1.19

0.47

3.5

5.0

u/ml

91.8

57.6

0.25

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

767

1.12

0.47

2.0

1.9

pmol/l

201.6

201.1

0.02

713

(3025577) Chromium [Mass/volume] in Blood

374

1.18

0.46

1.6

2.0

ug/l

1.6

2.1

1.14

312

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.45

0.44

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.45

0.44

2.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.37

0.44

1.0

1.1

—

(40761535) Cells panel - Urine sediment

460

4405

1.05

0.43

4.6

3.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

101

916

1.10

0.42

1.2

1.4

e6/l

18.7

21.4

0.09

716

(3000764) Benzodiazepines [Presence] in Urine

537

1.14

0.42

2.0

1.9

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.56

0.42

2.4

3.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.43

0.41

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

167

1.26

0.41

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

7.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.36

0.41

1.1

1.5

—

(3006462) Nitrate [Presence] in Urine

250

1.20

0.40

4.9

4.1

—

(4198724)

1.36

0.40

1.2

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

266.8

—

(3014271) Vancomycin [Susceptibility]

354

1.16

0.38

2.9

3.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

609

1.12

0.37

1.7

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

116

1.29

0.37

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

152

1.25

0.37

20.7

16.4

nmol/l

1407.7

1426.4

0.04

147

(4211845)

272

1.18

0.36

4.7

3.9

—

(40768793) Breast Pathology biopsy report

860

1.09

0.35

1.5

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

153

1.24

0.35

1.8

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.40

0.35

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.36

0.34

1.0

1.2

u/l

7.8

11.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.36

0.34

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.34

0.34

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

145

1.24

0.33

1.7

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

127

1.26

0.33

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.33

1.0

—

(3023410) Appearance of Cerebral spinal fluid

397

1.13

0.32

1.3

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

169

1593

1.06

0.31

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.30

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

108

1160

0.93

0.30

3.1

2.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

287

1.15

0.30

2.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

106

1136

0.93

0.28

6.6

3.8

mg/l

28.7

29.7

0.11

738

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

393

1.12

0.28

1.1

—

27.8

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

140

1.21

0.27

1.6

1.4

pmol/l

17.9

16.6

—

110

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

116

0.78

0.27

1.3

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

471

1.10

0.26

1.2

mmol/l

7.3

7.6

0.35

338

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

113

1.24

0.26

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.28

0.26

2.5

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

141

1.21

0.26

1.5

1.4

g/l

12.6

14.8

0.39

110

(3011985) Renin [Units/volume] in Plasma

608

1.09

0.24

1.3

1.4

mu/l

51.2

59.7

0.22

527

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

647

1.08

0.24

1.1

iu/ml

73.1

66.6

0.04

131

(3020874) Milk IgE Ab [Units/volume] in Serum

133

1.20

0.24

1.0

1.1

u/ml

0.8

2.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

1.21

0.24

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

1.20

0.22

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.22

0.22

1.2

4.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

116

1.21

0.22

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.19

0.21

2.2

2.1

umol/l

15.6

18.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.9

—

45.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

1.8

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

2.2

—

(4133840)

101

0.79

0.21

1.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

418

4286

0.97

0.20

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.25

0.20

1.8

1.3

—

640.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.22

0.20

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

115

0.78

0.20

1.1

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.20

0.19

14.7

11.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

165

0.85

0.19

1.4

1.9

e6/l

1716.2

20152.0

—

101

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4522

45078

1.01

0.17

5.4

5.3

mmol/l

2.5

2.6

10.30

4048

40692

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

148

1.15

0.16

17.3

11.4

nmol/l

888.6

824.0

0.22

138

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

267

0.90

0.16

1.5

1.4

pmol/l

60.2

165.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4404

43902

1.01

0.16

4.9

4.7

mmol/l

4.4

4.5

6.43

3944

39836

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

188

1822

1.03

0.15

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

226

1.11

0.15

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

898

1.05

0.15

1.9

1.5

nmol/l

1.1

0.8

1.82

739

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

236

1.10

0.14

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

488

1.07

0.14

2.3

3.2

mg/l

63.4

47.6

0.24

378

(4094501)

119

1237

0.96

0.14

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4362

43496

1.01

0.14

4.8

4.7

mmol/l

1.4

4.05

3877

39165

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.82

0.13

1.5

ng/l

183.9

160.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

170

1.12

0.13

1.2

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

114

1.14

0.11

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

312

0.93

0.11

6.8

13.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

347

1.07

0.11

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

188

0.90

0.11

2.0

2.2

umol/l

65.7

55.8

0.38

149

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

136

0.88

0.11

2.0

2.1

ug/l

1.3

0.01

128

(3006653) Thiamine [Moles/volume] in Blood

229

0.92

0.10

1.0

1.2

nmol/l

136.8

139.9

0.08

229

(4024509)

545

1.05

0.10

1.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.14

0.10

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2163

21528

1.01

0.10

4.8

5.4

ug/l

3.6

3.9

0.18

1874

19106

(3026480) Teichoate Ab [Titer] in Serum

1.06

0.09

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

186

0.91

0.09

1.9

2.1

e6/l

326.0

4827.5

—

136

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

110

1070

1.03

0.09

1.6

1.7

—

(4212803)

1.09

0.08

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.07

0.08

1.3

2.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

216

0.93

0.08

1.4

1.3

mmol/l

6.1

0.07

202

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

226

0.93

0.08

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

140

1370

1.02

0.08

2.6

2.3

ug/min

130.0

101.3

0.40

796

(3033799) Differential panel - Peritoneal fluid

166

1.08

0.07

2.2

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.84

0.07

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.86

0.07

2.5

2.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.12

0.07

1.5

1.2

umol/24h

0.8

0.7

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

128

1.09

0.06

2.0

2.2

mmol/l

7.6

8.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

114

1117

1.02

0.06

2.0

1.7

mg/l

28.3

3.5

6.48

797

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

175

1775

0.99

0.05

3.3

3.8

u/ml

61.0

74.7

0.34

170

1702

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

1.10

0.05

1.2

1.1

—

(4146454)

634

1.03

0.05

2.4

2.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

0.92

0.05

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

353

0.96

0.04

10.3

2.6

—

(3022689) Creatine [Moles/volume] in Urine

130

0.92

0.04

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

292

0.96

0.04

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

734

0.98

0.03

1.6

1.5

pmol/l

168.2

234.6

0.69

711

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

311

0.96

0.03

1.1

1.2

mmol/l

13.9

11.7

0.63

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

204

1.03

0.00

1.2

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

924

1.01

0.00

1.8

1.7

iu/l

4.8

0.00

289

(3024869) Neuronal Ab [Presence] in Serum

106

1.04

0.00

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

124

0.97

0.00

1.0

1.1

u/ml

0.6

2.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

103

0.97

0.00

1.9

3.3

—

(44806420)

194

0.98

0.00

2.0

2.4

—

(3006270) Folate [Moles/volume] in Blood

469

1.00

0.00

1.1

1.2

nmol/l

295.2

337.1

0.68

371

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.00

0.00

2.2

1.1

umol/24h

1.9

1.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(4038314)

0.00

0.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

7.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1364.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

2864.4

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

40.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.91

0.00

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

0.90

0.00

1.5

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.02

0.00

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.99

0.00

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.2

—

0.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.9

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

16.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.88

0.00

1.0

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.02

0.00

1.2

1.5

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL – ILD, hospital admissions

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions (ILD_HOSPITAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints